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Introduction 
Membrane proteins are one of the main components of cell membranes and serve for 
a variety of functions: transport, structure, signaling, cell communication, etc. Studies of 
membrane proteins are of high importance for understanding the key processes that maintain 
a cell in a viable state. With the help of membrane proteins cells grow, proliferate, exchange 
information with neighbors. Most of the cellular sensory systems are represented by 
membrane proteins. These proteins are particularly interesting for pharmaceutical 
applications and 70% of drugs are targeted to membrane proteins. 
After the importance of studying membrane proteins was understood, a lot of methods 
were developed and adapted to address fundamental questions of their functioning. X-ray 
crystallography has become a method of choice for studying membrane proteins and 
complexes, since it allows researchers to obtain the atomic level structure of proteins. 
Structural information, then, often reveals the design of the active site. By crystallizing the 
protein together with the ligand one can trap it in an active state and explain, by such 
structures, the mechanism of functioning. 
Despite the well-established importance and wide interest, the number of the 
structures of membrane proteins available at the moment is small. The rate of appearance of 
membrane protein structures is lagging considerably behind that for water-soluble proteins. 
The reasons for that are difficulties that researchers encounter at the stages of protein 
preparation and crystallization. Overexpression of a membrane protein in E.coli is a tough 
task. Normally, the expression levels would be very low. Also, solubilization and purification 
steps are not straightforward and require many routine screenings of conditions. 
Crystallization, as the last step of crystal preparation, remains the main stumbling block to 
the membrane protein structure. The proteins solubilized in detergents are usually unstable 
and don’t retain native structure. They yield crystals of poor quality. New crystallization 
methods have emerged and developed during the last decade. One of these methods, the in 
meso approach [1–3], was used in this study. 
Two-component signaling systems (TCSS) [4,5] comprise a class of proteins that has 
acquired recently a potential interest of researchers. In contrast to eukaryota, most 
prokaryotic signal transduction pathways use schemes of phosphate transfer involving two 
conserved components, a histidine protein kinase (HK) and a response regulator protein 
(RR). To the moment, hundreds of such systems were found in eubacteria, archaea and a few 
 7 
 
eukaryotic organisms. Two-component systems serve as a general stimulus-response  
mechanism of coupling that allow organisms to feel and react to changes in many different 
environmental conditions (for a review see [4]). Though a lot of advances in the field of 
signal transduction in TCSS have been made recently, there is still a strong demand for 
robust model systems where the molecular mechanism of signal transduction can be studied. 
The complex of the two membrane proteins from halobacterium N.pharaonis, sensory 
rhodopsin II (SRII) with its cognate transducer (HtrII), is an example of the TCSS system, 
where the signal transduction was studied in detail. This complex is serving as a phototaxis 
receptor that helps bacteria to avoid harmful UV light. It is unique for combining two huge 
independent classes of membrane receptors – 7TM (7-transmembrne helices) and two-
component signaling systems, being the first component of such system. Sensory rhodopsin 
II belongs to the family of archaeal retinal proteins, were members are represented by 
bacteriorhodopsin, halorhodopsin, sensory rhodopsin I etc. Another protein in the complex, 
halobacterial transducer II, is highly homologous to bacterial chemoreceptors and histidine 
kinases (HK). All chemoreceptors share a common modular design and modules are included 
depending on the function of the receptor. HtrII consists of a transmembrane domain, a linker 
domain (between two HAMP domains), a methylation region, involved in the adaptation to 
the intensity of light, and a kinase domain.     
The X-Ray structure of SRII/HtrII gives a unique insight into the complex of two 
transmembrane proteins [6,7] (PDB code 1H2S, 2F95). These structures elucidate initial 
steps of signal transduction in SRII and a possible mechanism of signal transfer to HtrII.  
Another representatives of TCSS, NMR structures of the cytoplasmic domain of the osmotic 
sensor EnvZ from E.coli have shown the design of the kinase domain that is highly conserved 
among all histidine kinases [8,9].  Despite this structural information there is still no detailed 
molecular mechanism of functioning of the complex from the initial step of retinal 
isomerization until the phosphate group transition to the kinase CheA. This work is aimed to 
elucidate some of these steps in detail and to show by means of X-Ray analysis the key 
features of protein structures that are prerequisite for efficient signal transduction. 
All halobacterial retinal proteins share common features of the signal transduction 
mechanism. One of these features is a proton transfer from the Schiff base to the counterion 
amino acid residue upon retinal chromophore isomerization. Various studies have shown that 
the mutation of the counterion to a neutral amino acid residue is critical for the function of 
most of them [10–12]. Asp75 is a Schiff base counterion in the case of SRII from archaea N. 
pharaonis. In the case of SRII/HtrII complex, physiological experiments have shown that 
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Asp75-to-Asn75 mutation doesn’t inhibit the signal transduction that is seen as persistent rate 
of cell motion reversals upon light illumination. This fact is important for understanding the 
signal transduction mechanism in these systems. The structure of SRII-D75N/HtrII described 
in our work shows the differences in the hydrogen bond network of the mutant complex with 
respect to the wild type complex. Its comparison with the ground and M states of the wild 
type has helped to understand how the signal transduction process might be evolved in D75N 
mutant protein. 
Extensive crystallization trials under various conditions have resulted into another 
finding that may be very important for understanding of the mechanism of functioning. 
Crystals of different space groups were produced and the structures in these space groups 
were compared to the previously published structures in the P21212 space group. A striking 
difference in the arrangement of the SRII and HtrII proteins in the complex was observed. 
Whereas in the P21212 space group the proteins form a crevice with an opening towards the 
cytoplasmic side (“V”-shape), in the newly obtained structure of I212121 space group the 
proteins are roughly parallel to each other (“U”-shape). This thesis contains an analysis of the 
biological relevance of the protein complex quaternary structures.  
The HAMP domain is a linker domain between the membrane and cytoplasmic parts 
of HtrII [13–16]. Though, it is abundant in different classes of proteins (found in more than 
4500 different genes), its function is still unknown. Several structures of the HAMP domains 
have already been published [17,18]. However, there are several drawbacks in these 
structures that hinder understanding of the mechanism of functioning. These structures were 
obtained with the truncated HAMP domain, which does not include other parts of the 
membrane protein. Unfortunately, the structures presented in this work didn’t reveal any 
sufficiently strong electron densities that could be used to build the structure of the HAMP 
domain. Possible reasons for that are discussed in the text. In order to get some structural 
information about the HAMP domain, some additional protein constructs were created, 
analyzed and set up for crystallization.      
Another part of this work is devoted to the study of histidine kinases NarQ and NarX. 
Histidine kinase chemoreceptors are a large family of transmembrane proteins that are found 
in many prokaryotes [19–21]. They are another representative of two-component signal 
transduction systems. As in case of photoreceptors, they comprise a sensor kinase protein and 
a response regulator protein and they are involved in the regulation of many cellular 
processes. NarQ and NarX belong to the family of histidine kinase receptors and react to 
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nitrate or nitrite to regulate anaerobic respiration in various bacteria. Activation/deactivation 
of transmembrane histidine kinase chemoreceptors has become a new target for the next-
generation anti-bacterial drugs [22]. Our study proposes some approaches that can be used in 
studying these very important proteins. First crystals of NarQ were obtained and optimization 
experiments are ongoing. 
During this study the following X-Ray structures were obtained: structure of the 
complex SRII/HtrII-157 in I212121 space group, structure of the SRII-D75N mutant in 
complex with HtrII-157, structure of the complex SRII/HtrII-135 in P64 space group, 
structure of SRII in a complex with HtrII-135-G83F mutant. Moreover, the membrane 
domain of the nitrate/nitrite receptor NarQ from E.coli was successfully expressed, purified 
and first crystals were obtained.        
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List of Abbreviations 
SK  Sensor kinase 
RR  Response regulator 
ATP  Adenosine triphosphate  
BR  Bacteriorhodopsin 
DDM  n-Dodecyl-β-D-Maltopyranoside 
ESI  Electrospray ionization 
HR  Halorhodopsin 
Hs  Halobium salinarum 
HtrII  Cognate Transducer protein of Sensory Rhodopsin II 
MALDI-TOF Matrix-assisted laser desorption/ionization – time-of-flight 
MO  2-mono-oleoyl glycerol 
MR  Molecular replacement 
MW  Molecular weight 
Np  Natronomonas pharaonis 
OG  Octyl-β-glucopyranoside 
RT  Room temperature 
SRII  Sensory Rhodopsin II 
TCSS  Two-component signaling system 
SB  Schiff base 
SEC  Size-exclusion chromatography 
HAMP1 First HAMP domain in NpHtrII sequence 
HAMP2 Second HAMP domain in NpHtrII sequence 
MCP  Methyl-accepting chemotaxis protein
1. Literature review 
1.1. Two component signal transduction systems 
Two-component signal transduction systems make bacteria able to respond to changes 
in extracellular environment. Many of such systems were found in both prokaryotes and even 
some eukaryotes (like plants, fungi and yeasts). No examples were found among animal 
species. Typical two-component system consists of a sensory protein from the family of 
histidine kinases and a coupled response regulator protein. This system transmits the signal 
from small ligands of the extracellular environment to the effector proteins in the cytoplasm 
[23,24]. The functional histidine kinase is always constructed as a homodimer. It is subjected 
to ATP-dependent autophosphorylation on a certain histidine residue in the cytoplasmic part 
of the protein and, afterwards, transfers the phosphoryl group to an aspartate residue on the 
cognate response regulator (RR). Thereby transcriptional, enzymatic or mechanistic properties 
of RR are changed. The RR is usually a cytoplasmic kinase protein [22,25]. These are the 
common features among this large family of signaling proteins (Figure 1.1). Moreover, for 
many two-component systems unphosphorylated sensor stimulates dephosphorylation of the 
phosphor-response regulator (also called transmitter phosphatase activity) [26,27]. The state 
of phosphorylation of the response regulator affects the function of its effector domain, which 
then calls an adaptive cellular response [5]. 
Such histidine kinase-mediated signal transduction chains are now found in the 
hundreds of species among prokaryotes, and evidences of their existence are reported for 
eukaryotes including yeast osmoregulation, fungi hyphal development, plant ethylene 
response and dictyostelium development [28]. Consequently, histidine kinases play an 
important role in signal transduction mechanisms among prokaryotes that is managed by 
serine/threonine and tyrosine kinases in eukaryotes [25]. 
 The major problem in the understanding of the signal transduction mechanism in 
histidine kinases has been the lack of availability of structural information. The dimeric 
histidine kinases, constructed from multiple modules, contain highly flexible hinges between 
these modules and posses difficulties for structural analyses. The success in structural 
determination in the area has come after the domains of CheA and EnvZ were identified. 
CheA is a cytoplasmic histidine kinase involved in chemotaxis [29], and EnvZ is a 
transmembrane osmosensing histidine kinase [30]. Identification of domain boundaries finally 
allowed solving high resolution structures of their independent parts. The three-dimensional 
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structures of the kinase domains of the abovementioned two histidine kinases (EnvZ [9]; 
CheA [31]) were determined, showing that the topology of the histidine kinase domain 
doesn’t have any resemblance to those of the previously determined structures of 
serine/threonine and tyrosine kinases. In contrast, they have defined a novel catalytic motif 
among other unique features. The structural studies also reveal that, although histidine kinases 
are composed of similar domains, they are diverse in their organization. These differences 
reflect their functions, localizations, and regulatory mechanisms in the cell [25]. 
 
Figure 1.1 Organization of the typical two-component signaling system (TCSS) in bacteria. The typical TCSS 
is comprised of a single transmembrane sensor kinase (SK) as the first component and a single cytoplasmic 
response regulator (RR) as the second component. The sensory domain of the SK recognizes a specific signal 
from the environment. This can be a chemical ligand or a photon. The sensing of the ligand results in 
stimulation of the kinase domain and autophosphorylation in the output domain of the SK at a certain 
histidine residue. The receiver domain of the RR is close to the output domain of the phosphorylated SK. The 
phosphate is transferred to the conserved aspartate residue of the receiver domain. Phosphorylation of the 
RR, in turn, affects its output domain, resulting in conformational changes in the RR that aid to call the 
response in the cell, including transcriptional regulation of particular genes. From [32]. 
The main objective that is not achieved so far is to understand the mechanism of the 
signal transduction through histidine kinases. Undoubtedly, it is the major challenge for the 
future research in this area. 
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1.2. The complex of Sensory Rhodopsin II (SRII) with its 
cognate transducer 
1.2.1. General characteristics and function in vivo 
Rhodopsins are seven alpha-helical membrane proteins and are present in all 
kingdoms of life [33,34]. Although structurally very similar, their functions are quite diverse 
as they can act either as ion pumps, cation channels, or sensors [35,36]. This broad diversity 
made microbial rhodopsins the target of an intensive research and of biotechnical 
applications. This has been demonstrated in the new field of optogenetics which utilized 
channel rhodopsin and halorhodopsin, a chloride pump, as tools in neurophysiological 
research [37]. 
 
Figure 1.2 The four archaeal rhodopsins 
in H. salinarum. The ion-pumping 
rhodopsins BR (a proton pump) and HR 
(a chloride pump) are shown together with 
the sensory rhodopsins SRI and SRII with 
components in their two-component signal 
transduction chains. From [35]. 
 
The complex of the two membrane proteins from halobacterium N.pharaonis, sensory 
rhodopsin II (SRII) with its cognate transducer (HtrII), is an example of the two-component 
signal transduction system. This complex serves as a phototaxis receptor that helps bacteria to 
avoid harmful UV light. It is unique for combining two huge independent classes of 
membrane receptors – 7TM (7-transmembrne helices) and two-component signaling systems. 
This is the first component of TCSS that transmits the photophobic signal to the flagellar 
motor. This complex displays a 2:2 stoichiometry where two transducers are flanked by two 
receptors (Figure 1.3). The long rod-shaped cytoplasmic domain consists of two HAMP 
domains (present in Histidine kinases, Adenylyl cyclases, Methyl-accepting proteins and 
Phosphatases [38,39]), which are followed by a methylation domain involved in the 
adaptation processes and a signaling domain which harbors the CheW/CheA binding site [40]. 
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The first HAMP domain (HAMP1, amino acid residues 83-135) and the second HAMP 
domain (HAMP2, amino acid residues 157-210) are connected with an α-helical linker (inter-
HAMP). Despite high abundance of HAMP domains in different classes of proteins, their role 
and function is still unclear [16,17,38]. In order to understand the signal transfer from the 
receptor to the transducer it is mandatory to determine the exact structure of the binding 
surface connecting NpSRII with its cognate transducer. Currently, the structure of the 
membrane domain is determined [6,7], however for the adjacent proximal region only indirect 
experimental evidences [41–44] are available. 
The whole process of signal transduction can be divided in the following steps. The 
complex captures photons of a specific wavelength and stores the energy of the photons in a 
chemical form in the active site of the protein consisting of retinal and neighboring protein 
residues. It uses the energy to create states, called signaling states, which have their distinct 
structural and spectral features. This leads to alterations in the SRII/HtrII interface. The 
changes in interaction between the receptor and the transducer are propagated to two distinct 
sites on the HtrII protein, first to a region called the signaling domain, causing alteration of 
autophosphorylation activity of a bound histidine kinase (CheA) and second to methylation 
regions, changing their susceptibility to methylation/demethylation (managed by proteins 
CheR and CheB). As a consequence, a new methylation level is set through the activity of 
methyltransferase and methylesterase enzymes. Methylation/demethylation processes reset 
the activity of CheA kinase to the prestimulus value in the case of continuous stimulation of 
the signaling process. Therefore, the overall output of this TCSS is a momentary change in the 
kinase activity that results into a momentary change in the level of phosphorylation of a 
cytoplasmic regulator protein (CheY). This process, in turn, causes a momentary change of 
the switching probability of the flagellar motor. The swimming reversal frequency in bacteria 
is normally measured as an output of the signal transduction [35].  
The SRII/HtrII signaling complex is a unique system of two membrane proteins that 
allows studying the properties of signal formation and relay, from the photo-biophysics of 
initial stimulation of the receptors to the final output at the level of the swimming direction 
reversals, revealing underlying principles of sensory transduction and more generally the 
nature of dynamic intercommunication between membrane proteins [35]. 
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Figure 1.3 General view on two-component signal transfer in case of the SRII/HtrII complex. The activation 
of the transducer HtrII by its receptor SRII leads to a conformational change of TM2 that propagates to the 
tip of the coiled-coil cytoplasmic domain. The signal is transferred from the kinase control domain to the 
cytoplasmic kinase CheA by means of phosphorylation. Then, the signal is relayed to the flagellar motor 
through the mediator CheY. The result is the change in the rate of reversals of the flagellar motor’s direction 
of rotation. From [7]. 
Previously, the crystal structures (space group P21212) of the wild type 
NpSRII/NpHtrII complex had been reported which display an overall “V”-shaped topology 
with the opening to the cytoplasmic side [6,7]. The structures contained HtrII truncated at 
positions 114 [7] and 157 [6] to optimize the construct geometry for formation of crystals in 
the cubic phase. Though, the structure of SRII contains nearly all amino acids except 
disordered C-terminus, only amino acids 23-82 were modeled for the HtrII protein. Computer 
modeling of the HAMP domain to the indention of the “V”-shaped structure did not show 
direct contacts of the receptor and the HAMP domain which is in contrast to presently 
available experimental evidences [41,42,45]. These clearly proved an interaction of TM2 with 
e.g. E-F loop. There could be several reasons for such a discrepancy, one of which could be 
the influence of crystallization conditions on the global arrangement of the proteins. There is 
so far a lack of information about how the structures of membrane protein complexes depend 
on crystallization conditions.  
Conformational changes in SRII in course of the photocycle were initially studied 
spectroscopically and attributed to different intermediate states with characteristic absorption 
spectra. After isomerization of the retinal, NpSRII thermally relaxes back to the original state 
through a series of intermediates [46,47]. The M intermediate which is formed in 10 µs is 
central for formation of the active state. The formation of M-state is accompanied by 
deprotonation of the Schiff base and concomitantly the protonation of Asp75 (this residue is 
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the analogue of Asp85 in BR).  Neutralization of the counterion complex Schiff base – 
Asp75 and subsequent M1-M2 transition plays an important role for signaling [48,49]. 
Therefore, it was expected that the substitution of Asp75 by neutral Asn75 will alter 
physiological properties. Nevertheless, the corresponding changes in the properties of the 
proteins were not observed in living bacteria. Interestingly, the analog mutation in H. 
salinarum (HsSRII-D73N) leads to constitutive activity [50,51]. The crystal structures of both 
wild type and D75N mutant complexes in its U-shaped structure provide an insight into the 
nature of transmembrane signal transfer. 
 
 
Figure 1.4 The structure of the ”V”-shape of the complex. The structure was solved in the P21212 space 
group. -Helices are shown in red for the receptor and in green for the transducer; β-strands are shown in 
blue and coils are shown in grey. Dotted lines indicate hydrophobic core of the proteins. V44 and A59 are 
residues that form hydrogen bonds between HtrII and SRII. Only membrane part of HtrII could be built 
(residues 22-82), though the molecular construct contained residues 1-114. From [7]. 
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1.2.2. Photocycle of Sensory Rhodopsin II. Intermediate states  
The absorption spectrum of SRII from N. pharaonis displays two features that are 
different from the spectra of the other archaeal rhodopsins. First, the maximum of SRII is at 
498 nm, lower wavelength as compared to BR (568) and HR (578). Second, the spectrum of 
absorption of the SRII protein shows vibrational fine structure at physiological temperatures 
[52]. 
 
Figure 1.5 The photocycle of sensory rhodopsin 
II from N. pharaonis. The retinal chromophore 
is covalently bound to a Lys-205 in helix G via a 
protonated Schiff base (double C=N bond). The 
primary reaction, light-induced isomerization of 
the all-trans retinal to 13-cis configuration, is 
the followed by thermal reisomerization to the 
ground state via highly specific spectral 
intermediates as indicated by the color of the 
retinal and the λmax of the intermediates. From 
[53]. 
The sequence of events, occurring after absorption of a photon by the protein is shown 
on the Figure 1.5. During the photocycle the retinal undergoes isomerization from all-trans to 
13-cis. The energy, acquired by this process, leads to the sequence of structural changes in the 
protein that are characterized by the specific changes in the absorption spectrum of the 
protein. Five spectrally distinct species are formed [46]. The chromophore states correspond 
in their spectral properties to those of the BR photocycle, namely pSRII-510 (K), pSRII-495 
(L), pSRII-400 (M), pSRII-485 (N) and pSRII-535 (O).  
The spectrum of SRII has a maximum at 498 nm and two shoulders at 460 nm and 420 
nm. Characteristic difference to BR is the absence of well-manifested L and N states. The M 
state is formed very fast and decays with a characteristic time of a few hundred milliseconds. 
In the K state absorption maximum is shifted by 10 nm to the red. Experimental information 
on the L state is quite poor. Primary reason is that it cannot be stabilized at low temperatures. 
The data obtained by dynamic FT-IR spectroscopy show that, as in the K state, the 
conformation of C14-C15 connection is different from the planar and structural changes have 
a greater amplitude than in the K state. The M state is characterized by the deprotonated SB 
and protonated Asp-75. In the M state the structural changes in the protein are the most 
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prominent. Slow decay of the M state is due to the lack of a proton donor. M state can be 
detected at temperatures below 220 K, while the IR spectra of M state are the same at low and 
room temperatures, indicating the identity of the structural changes. In the O state the retinal 
is in all-trans conformation. SB is again protonated. In addition, the carboxyl group of one of 
the glutamine or asparagine amino acids is protonated, while the other, also unknown, 
carboxyl group is deprotonated [54]. 
Intermediate states are, in the first place, spectroscopically distinct states, which reflect 
the changes in the immediate vicinity of the retinal. Structural changes far from retinal pocket 
do not produce changes in the absorption spectrum. During all the states of the photocycle 
from K to O the retinal is in the 13-cis conformation. The transition to all-trans happens upon 
transition from O to G. 
While the shifts of the absorption maxima (λmax) to the red and slightly to the blue in 
the K and L states, respectively, reflect changes in the strength of the salt bridge between the 
SB and the counterion complex [55], the much larger blue shift of the λmax upon M 
formation reflects deprotonation of the Schiff base by the Asp75 anion, thereby disrupting the 
salt bridge. 
1.2.3. The role of HAMP domains in cell signaling   
Microbes react to changes in the environment in a variety of ways. Changes of 
environmental conditions can open opportunities in ways of nutrition and possess potential 
danger to their lives. Correspondingly, bacteria and archaea use a certain set of sensory 
systems to feel their living conditions. These sensory systems have a fundamental role in the 
life cycle and their functional mechanism can be split into the following steps: detection of an 
extracellular stimulus, transmission of the stimulus across the cellular membrane and 
conversion of that information to a signal that triggers a change in behavior of the bacteria or 
gene expression of certain effector proteins [13]. 
A lot of signaling proteins from bacteria include HAMP domain signaling motifs. The 
name “HAMP” is used because they are found in such abundant classes of proteins as 
histidine kinases (HKs), adenylyl cyclases, methyl-accepting chemotaxis proteins (MCPs) and 
some phosphatases. In transmembrane receptors HAMP domains are typically located near 
the cytoplasmic side of the membrane. Their function is predicted to be the conversion of the 
transmembrane and extracellular sensory inputs to output response signals in the cells. All the 
signaling chemoreceptors function as homodimers. HtrII is an MCP-like phototransducer of 
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sensory rhodopsin II that is found in two archaeal halobacteria Halobacterium salinarum (Hs) 
and Natronomonas pharaonis (Np). It is a cognate signaling protein of the SRII receptor. The 
HtrII molecule has an MCP adaptation domain (ruled by the methylation process of certain 
glutamate residues) and kinase control domain preceded by two HAMP domains connected 
through a linker helix and two transmembrane helices. NpHtrII has no periplasmic domain 
and the transmembrane helices are connected via a short extracellular loop. Meanwhile, 
HsHtrII has a periplasmic domain that has been found to be involved in serine chemical 
sensing [13]. 
In vitro spectroscopy studies [14,43,44] have provided some structural information for 
the first NpHtrII HAMP domain. There is no structural information for the second HtrII 
HAMP domain and the mutational information for this system is also insufficient. Spin-
labeling studies of an HtrII fragment containing membrane part, HAMP-1 and the inter-
HAMP helix, reconstituted in complex with SRII into lipids, showed that the HAMP-1 
domain is in equilibrium between two conformations: compact and dynamic [56]. The ionic 
strength of the buffer and temperature changed the ratio between the two forms, and the 
compact form was suggested to resemble the tight bundle reported for the HAMP domain 
from the putative gene Af1503 [38]. Trypsin cleaved a similar, solubilized HtrII fragment in 
the AS1 segment of HAMP-1, yielding a C-terminal fragment in which only the linker helix 
had a discernible NMR solution structure [13,57].  
1.2.4. Known structures of HAMP domains and molecular modeling  
HAMP domains are special types of coiled-coil motifs that are defined by a few 
conserved residues. These residues form characteristic hydrophobic heptad repeats and are 
predicted to form helical and non-helical secondary-structure elements. HAMP subunits are 
typically about 50 residues long, with two helices joined by a non-helical connector. Heptad 
repeats form a hydrophobic core between helices in a functional HAMP domain. The two 
HAMP domains of HtrII are connected with an α-helical linker normally called as inter-
HAMP. HAMP secondary-structure elements have been given diverse names, and their 
boundaries are also variously defined. In this work the notations AS1 and AS2 for alpha-
helices and CTR for the connector between them will be used as most common in literature 
[13]. The corresponding elements of the symmetry related HAMP will be designated with a 
prime. 
Recently, Hulko et al. [18] have published a high-resolution NMR structure for a 
HAMP domain from a protein of unknown function from a thermophile organism (Af1503), 
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an important breakthrough that has paved the way for the following work on HAMP domains. 
The Af1503 HAMP structure exposed a parallel, four-helix cluster with each interhelical 
connector bundled up around the outside of the cluster in contact with the two helices from 
the single monomer (Figure 1.6). The AS1 and AS2 helices are offset by one helical turn in 
the cluster.  
The main packing interactions occur between the characteristic heptad repeat hydrophobic 
residues. It was found that the structure-defining residues in the HAMP domain sequences 
occupy key positions in the Af1503 cluster structure. Using Tsr nomenclature, these residues 
are: P221 (AS1) and E248 (AS2) (both lie at the N terminus of the bundle), and A233 (AS1) 
(lies at the C terminus of the bundle). G235 is a conserved residue at the start of the 
connector. It forms a flexible hinge to make a sharp turn in the structure. L237 and I241 are 
typically hydrophobic amino acids whose side chains pack against the AS1 and AS2 helices 
to stabilize the bundle [18]. The latter residues are not conserved among all HAMPs. 
 
Figure 1.6 A stereo picture of the HAMP domain dimer. The structure was obtained by NMR spectroscopy 
(PDB code 2ASW). The solution structure of an archaeal HAMP domain Af1503 showed a homodimeric, 
four-helical, parallel coiled coil bundle with an unusual interhelical packing knobs-to-knobs, related to the 
canonical packing by rotation of the helices. From [18]. 
The Af1503 HAMP structural packing is not orthodox. The third position, usually 
occupied by a small, but not necessarily hydrophobic is not normally contributing to the 
structure of HAMPs. In Af1503 this residue also contributes to the HAMP domain packing. 
The new discovered possible HAMP domain packing was called x-da, or knobs- to-knobs. It 
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is characterized by the structure where the side chains of some hydrophobic residues protrude 
into the core of the HAMP cluster and make contact with their counterparts of the other 
subunit, whereas the side chains of the neighboring hydrophobic residues interact with similar 
residues in the other helix of the same subunit. Similarly, the less hydrophobic residues are in 
touch with the similar residues in the other helix from the other subunit. This packing 
arrangement is different from the more commonly observed a-d or knobs-in-holes packing of 
coiled-coil structures, although the heptad repeat pattern of hydrophobic residues is common 
to both [18]. 
The Aer2 protein of Pseudomonas aeruginosa contains three consecutive HAMP 
domains whose X-ray structures have been determined recently [17]. The first and the third 
Aer2-HAMP domains were found to have a cluster structure similar to that of Af1503-
HAMP. Nevertheless, variations on the packing arrangements of the hydrophobic residues 
were also observed. These four-helix clusters, in which all AS1 and AS2 hydrophobic 
residues are involved in cluster-stabilizing knobs-to-knobs packing interactions are represent 
a widely spread HAMP structural state, which is normally called HAMP(A) [13]. 
 
Figure 1.7 The crystal structure of the N-terminal domain of the soluble gas-sensing receptor Aer2 that 
contains three successive HAMP domains. Ribbon representation of the Aer2 (1–172) dimer with HAMP1, 
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HAMP2 and HAMP3 is shown. From [17]. 
The second HAMP domain of Aer2 has a considerably dissimilar structure that may 
represent a possible alternative conformation of HAMP domains. This structure is denoted 
HAMP(B) and in literature is called a loose cluster or bundle. In the structure of HAMP-2 the 
four helices also have parallel orientations. In contrast to HAMP-1 and HAMP-2 these helices 
are less tightly packed and tilt apart from one another. They form a trapezoid shape where 
AS1 and AS1’ are near each other at the top of the bundle, and AS2 and AS2’ are closest at 
the bottom of the bundle (Figure 3b). The three C-terminal hydrophobic residues (L256, 
M259, L263) modulate the packing of the AS2/AS2’ helices against one another in an 
arrangement different from that in the HAMP(A) bundle [17]. The different packing 
conformation is stabilized by the crucial hydrophobic connector residues: one (L237) packs 
against the last hydrophobic residue of AS2 from the other subunit (L263’); another (I241) 
packs against the first of the three C-terminal hydrophobic residues from the same subunit 
(L256) [13]. In general, HAMP-2 forms a unique fold for the HAMP domains never observed 
before and referred to as ridges-into-grooves interaction. 
1.2.5. The molecular mechanism of signal transduction  
The retinal chromophore switches from all-trans conformation to 13-cis and 
simultaneously shifts towards the central water cluster. The side group of Asp75 is rotated by 
about 90° from its ground state position, thereby losing the hydrogen bond to Thr79. 
Consequently, W3 becomes disordered and disappears in the M-state. Hydrogen bonds 
pentagon (Asp201-Oδ···W2···W1···W4···Arg72-Nε) does not exist anymore in the M-state 
because molecules W2 and W4 have vanished (Figure 1.8). Consequently, helices C and G 
have more freedom to move independently. The helical segment between Pro71 and Pro81 in 
the helix C is displaced towards the active center by 0.4 Å with respect to the ground state. 
Water molecule W2' shifts towards Asp75 and Arg72. Water W1, which forms a bridge from 
Asp201 to Asp75, vanishes in the M state. Thus, the signal is generated by retinal 
isomerization and then propagates to the interface between the receptor and the transducer. 
The signal propagation is driven by the rearrangement of the hydrogen bond network 
mediated by water molecules that leads to the movement of the receptor helices described 
above due to the loss of connectivity between C and G helices. These results are in agreement 
with those obtained for the symmetry P21212 [6].  
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Figure 1.8 Structural changes in the vicinity of the retinal upon transition from the ground to the M state. 
Ground state is shown in red, M state is shown in yellow; a – changes in SRII, b – changes in BR. Difference 
density maps are contoured at 3σ. Primes denote water molecules of the M state. From [6].  
The movement of the helix G of NpSRII initiates the movement of TM2 in NpHtrII.  
The hydrogen bonds between receptor and transducer are shown to be the same in both the 
ground state and the M-state. A piston-like movement of the cytoplasmic end of TM2 by 
about 0.5 Å and rotation of 15° was observed and accompanied by alteration in the direction 
of Tyr199-Asn74 hydrogen bond. The similarity of the differences between the ground and 
the M-states in the new crystals shows an overall robustness of the signal transduction 
mechanism. 
Structural changes in the positions of the helices observed upon the ground to the M-
state transition are the same in both I212121 and P21212 crystals, though there is a small 
difference in the amplitudes of changes for some helices. One can determine two groups of 
helices that make cooperative movements (ABG and CDEF).  Helix G moves towards the 
transducer and the extracellular side. The magnitude of the shift is not the same through the 
helix, being the biggest at the C-terminus (about 0.5 Å) [6]. 
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Figure 1.9 Structural rearrangements in the position of helices F, G, TM1 and TM2 observed in the membrane 
plane. The ground-state complex is shown in red and the late M-state complex in yellow; black numbers give 
distances between Cα atoms of the following amino acids in the ground and late M states: F(Leu 170) to 
TM2(Leu 77), ground state 7.4 Å, M state 8.0 Å; G(Val 203) to TM2(Leu 77), ground state 8.3 Å, M state 7.8 Å; 
TM2(Val 78) to TM2'(Val 78), ground state 12.0 Å, M state 12.3 Å. SRII can be divided into 2 sections: the first 
containing helices A, B and C and the second containing helices D, E, F and G. The arrows on TM1 and TM2 
depict displacements parallel to the membrane plane in the late M state; the thick arrow on helix G depicts its 0.5 
Å movement to the extracellular side. A clockwise rotation of 15° was observed for TM2. An in-plane 
displacement of 0.9 Å (black arrow) near the cytoplasmic membrane surface in late M state with respect to the 
ground state was also detected. The red line in the receptor on the right divides the molecule into the two 
functionally important domains ABG and CDEF. The inner red shaded circles of helices A, B and G depict their 
movements to the extracellular side. Illustration from [6]. 
Two possible mechanisms of TM2 communication with HAMP have been suggested 
in literature. The first is a crankshaft and gearbox mechanism that involves an axial rotation of 
TM2 segments around the axis of the helix in the plane of the membrane. The second is a 
piston mechanism that is manifested in displacements of the TM2 helix perpendicular to the 
plane of the membrane by 0.5 to 1 Å. The crankshaft and gearbox model arose from the NMR 
structure of a putative gene Af1503 [18].  In this study it was discovered that an x-da bundle 
should exist alternative to the orthodox a-d packing, differing by a about 26° counter rotation 
of the four helices [13]. Nevertheless, other structures of histidine kinases don’t support this 
theory and are rather in favor of the piston-like mechanism. 
Evidence for the piston motion mechanism in bacterial chemoreceptors has come from 
comparison of the apo- and ligand-bound structures of the Tar periplasmic domain, from 
disulfide formation rates of cysteine reporters in the TM segments of chemoreceptors and 
from the signaling changes caused by relocating the aromatic and basic anchor residues that 
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secure the position of TM segments in the membrane bilayer. Also, the recent results on the 
HAMP domain structure support this hypothesis[16]. Motions that move TM2 toward the 
cytoplasm enhance CW output activity, whereas shifts in the opposite direction enhance CCW 
signaling. Thus, outward piston-like movements in chemoreceptors simulate a repellent 
stimulus and inward displacements simulate an attractant stimulus. The small vertical shift is 
consistent with the calculated free energy change of ligand binding [13,23,58]. 
1.2.6. O-like D75N mutant of SRII  
Conformational changes in SRII during the photocycle were initially studied 
spectroscopically and attributed to the different intermediate states, each with its own 
characteristic absorption spectrum. After the isomerization of retinal, NpSRII thermally 
relaxes back to the original ground state through a series of intermediate states [46,47]. The M 
intermediate, which is formed in 10 µs, is the key intermediate for the evolution of the active 
state. The formation of M state is escorted by a deprotonation of the Schiff base and 
accompanying protonation of Asp75. This residue is forming a salt bridge with the Schiff 
base. Asp75 is an analogue of Asp85 in BR. Neutralization of the counterion complex Schiff 
base – Asp75 and the following M1-M2 transition play an important role for signaling in SRII 
and SRII/HtrII complex [48,49]. 
Counterions of Schiff base, analogous to Asp75 in NpSRII, are found in all retinal 
containing proteins [59,60]. The most studied so far is the function of Asp85 in molecular 
mechanism of proton pumping in bacteriorhodopsin [61–65]. Asp85 acts as an acceptor of the 
Schiff base proton. Replacement of Asp85 by neutral Asn leads to dramatic changes in the 
photocycle and pumping activity of BR. These changes are different depending on pH of the 
buffer. At neutral pH the photocycle of the D85N mutant contains only L and N 
intermediates. No M state is observed in this case. Since the change of Asp85 to Asn85 
decreases the net negative charge at the active cite, the pKa of Schiff base is therefore 
decreased from 13 to around 8-9. Therefore, the proton is not tightly bound in the mutated 
protein and a mixture of protonated and deprotonated retinal forms with corresponding 
isomerization states can be observed showing absorbance peaks at 610 nm and 410 nm 
respectively [66]. Depending on conditions of illumination different manners of proton 
transfer were found for the D85N mutant of BR. Upon excitation with the blue light the 
protein stationary current is in the same direction as in the wild type protein. Two-photon 
excitation (yellow and blue) reverses the direction of pumping [67]. In halorhodopsin (NpHR) 
the homologous residue corresponding to Asp75 in NpSRII is Thr126. It was found to be not 
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crucial for the process of chloride pumping. The influence of T126V mutation on chloride 
affinity was found to be negligible and the time constants of the photocycle were not changed 
considerably [68]. Another phototaxis receptor, sensory rhodopsin I, exists as a mixture of 
two different functional forms depending on pH. At low pH it acts like a phototaxis 
transducer in the complex with HtrI. In high pH environment it is converted into a proton 
pump similar to BR. In this protein Asp76 residue acts as a Schiff base counterion and proton 
acceptor for the alkaline, BR-like form. In this case D76N replacement leads to spectral 
changes similar to that in BR. On the contrary, in the acidic form Asp76 is already protonated 
and D76N mutation has no substantial influence on the function of the protein [65]. 
 
Figure 1.10 Proposed reaction schemes of 
photocycles of the D75N mutant of SRII 
(dotted arrows) and the complex SRII-
D75N/ Δ NpHtrII (solid arrows). The 
numbers indicate the lifetimes of each of 
the intermediates. From [69]. 
Two more proteins where the Schiff base counterion has a drastical influence on the 
phenotype are sensory rhodopsin II from H. salinarum (HsSRII) and human rod rhodopsin. In 
the HsSRII D73N and in the rod rhodopsin E113Q mutants constitutive activity of the 
pigments is observed [11,50]. 
Therefore, it was expected that the substitution of Asp75 by neutral Asn75 will alter 
physiological properties. Nevertheless, this was not observed experimentally [46,50]. Using 
transient grating analysis (TG) it was demonstrated that D75N-HtrII functions in phototaxis 
signaling despite the absence of a deprotonated Schiff base. The interpretation of this fact was 
suggested by authors. They propose that the retinal isomerization followed by proton transfer 
from the Schiff base to Asp75 may be necessary for signaling in the wild-type complex. 
Nevertheless, in D75N the Schiff base deprotonation is not obligatory, because Asp75 is 
replaced with a neutral residue imitating the protonated Asp75. The TG analysis has revealed 
four spectroscopically silent K-like intermediates (K1–K4) in the D75N protein with certain 
volume differences. The time constants for the interconversions were 76 ns, 460 ns, 130 ns, 
8.0 ms, and 81 ms correspondingly (Figure 1.10). 
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 Interestingly, the analog mutation in H. salinarum (HsSRII-D73N) leads to 
constitutive activity [50,51]. 
1.2.7. Signal abolishment in the G83F mutant of HtrII  
 Residue Gly83 in NpHtrII is important for maintaining the NpHtrII in a functional 
conformation. No phototaxis response was reported when Gly83 was mutated to cysteine or 
phenylalanine. Meanwhile, the phototaxis remained when Gly83 was replaced by alanine. The 
interpretation is that replacement of Gly83 with a more bulky residue eliminates the 
phototaxis response [70]. The same authors reported a large decrease compared to wild type 
in cross-linking efficiency in the dark was measured in G66C-G83F and L75C-G83F double 
mutants. It was suggested that the two helices TM2 and TM2‘ have become more separated or 
have become more flexible as a result of the G83F mutation. It was observed that the 
construct with two mutations G66C-G83F exhibited no detectable cross-linking in the dark 
and only a slightly detectable level after 3 min in the light. In NpHtrII containing mutations 
L75C-G83F, for which the efficiency could be measured, light still increases the cross-linking 
efficiency, showing that the NpSRII and NpHtrII are still coupled in a functional complex. 
The cells with HtrII-G83A mutation showed phototaxis responses similar to the response of 
the wild type whereas no phototaxis response was observed in the case of G83F mutation.  
The conclusion can be drawn that bulky residues at position 83 inhibit the signal transduction 
whereas small residues don’t. Another study has reported an absence of FRET signal between 
EF loop at position 154 and HtrII-G83F while in the case of wild type HtrII the signal was 
detected [42]. 
Worth noting that these findings are in line with the “V”-shape quaternary structure of 
the SRII/HtrII-G83F complex discussed in Chapter 3.7. 
1.3. HAMP domain containing histidine kinases NarX and 
NarQ from E. coli 
Nitrate (NO3
-
) and nitrite (NO2
-
) are exploited by bacteria as efficient respiratory 
oxidants in the phase of anaerobic growth. The two-component sensory systems NarX-NarL 
and NarQ-NarP act together in E.coli to control anaerobic gene expression in response to 
nitrate and nitrite. These proteins belong to the family of homologous nitrate reductases (Nar). 
Analysis of gene-deficient mutants has revealed that only one of the NarX or NarQ sensors is 
sufficient for NarL-dependent activation of narGHJI operon transcription. These observations 
provided an indication that the Nar regulators form a signal-responsive cross-regulation 
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network. Recent results show that this interaction network is asymmetric: although the NarQ 
sensor exhibited similar transmitter phosphotransferase activities for both the native NarP and 
NarX-connected NarL response regulators, the NarX sensor by contrast has shown a apparent 
predilection for phosphotransfer to NarL [26]. 
An extensive analysis of NarX and NarQ sequence was done by Dr. V. Stewart and 
coworkers [71]. The unique feature of response to nitrate and nitrite in Escherechia coli (and 
Salomonella enterica) is that they have both systems (NarX-NarL and NarQ-NarP) while 
other studied bacteria have only one of that. 
 
Figure 1.11 Sequence alignment of NarQ and NarQ chemoreceptors with the most studied MCP – EnvZ. 
Distinct domains including 2 transmembrane helices and the HAMP domain were identified. From [71]. 
Crystal structure of NarX periplasmic domain was successfully solved [23]. The 
structures include apo- and nitrate-bound states and reveal a four-helix bundle. The all-helical 
fold is similar to that of the aspartate receptor Tar. The location of a single ligand binding site 
at the dimer interface is unique in NarX and is not found in other chemoreceptors. This 
binding site involves residues of both protomers. The important role of Arg54 in nitrate 
binding was found to be consistent with biochemical and genetic studies of NarX [71]. The 
nitrate binding is mediated by the hydrogen bonding with the side chains of Arg54 and 
Arg54’ (Figure 1.12). This structure contrasts with aspartate binding by Tar where 
interactions between protein and ligand involve indirect hydrogen bonding involving water 
molecules. The nitrate occupies the unique binding site in NarX in quasi-symmetric manner. 
It different from the asymmetric binding of aspartate to chemoreceptor Tar, where only one of 
the two available binding sites is completely occupied [23].  
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Figure 1.12 The extracellular nitrate-binding site of 
NarX. Two protein chains, H1 and H1’, forming a 
homodimers are shown. Arg54 residue participates in 
ligand binding. The binding is symmetric. From [23].  
 
The conformational changes that happen within the sensory domain of NarX after nitrate 
binding are similar of those in the chemoreceptor Tar, in which a displacement of about 1 Å 
between the N- and C-terminal helices of the periplasmic domain was also observed upon 
ligand binding. The structural alterations in NarX were found to occur symmetrically between 
the two monomers as the binding of nitrate is symmetric, whereas in Tar they appear to be 
localized in only one of the subunits due to asymmetric aspartate binding [23]. 
1.4. Crystallization of membrane proteins 
Membrane proteins are the major functional components of cell membranes and 
constitute about one-third of the proteins encoded in the genome [72]. Study of membranes at 
the molecular level is of great importance for deciphering all cellular processes and drug 
design. Moreover, about 70% of currently available drugs focus on membrane proteins 
[73,74]. However, although the number of membrane proteins of known structure has 
increased recently, it is not yet comparable to the same indicator for the water-soluble 
proteins. 
According to the database of membrane proteins of known structure 
(http://blanco.biomol.uci.edu/Membrane_Proteins_xtal.html) to date, only 360 of the more 
than 70 000 registered high-resolution protein structures are among the unique membrane 
proteins. This fact is usually accounted for by the amphiphilic nature of membrane proteins 
and difficulties associated with their instability outside of natural membrane environment. 
There are total 4 methods for crystallization of membrane proteins described in literature: 
standard crystallization of solubilized proteins (in surfo), crystallization from bicelles [75], 
crystallization from vesicles [76] and in meso approach [77,78].  As the first two methods 
didn’t show wide applicability among various membrane proteins, the structures described in 
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this study were obtained mainly by the last method. It has proven to be a method of choice for 
crystallization of difficult targets as it allows crystallization in a native lipid environment.  
Despite a big success of the method, especially in crystallizing of GPCR receptors [79–81], 
the detailed mechanism of the crystallization process in meso is still unknown. This method 
yields crystals that belong to type I, where proteins are oriented in a parallel manner in layers, 
in contrast to conventional crystallization that gives crystals of type II (Figure 1.13). 
Normally, crystals of type I have much better quality and yield data of much higher 
resolution. Each crystallization target requires a massive screening of conditions that are 
optimal for the formation of high quality crystals. Moreover, by tweaking of the conditions, 
crystallization constructs and additives one can change phase properties and cell parameters 
of the resultant crystals. 
In meso method was introduced by Landau and Rosenbusch in 1996 [3]. In this case 
crystallization occurs in a lipid matrix in a liquid phase (meso phase). Crystallization in the 
cubic phase was the first method to crystallize membrane proteins, in which a lipid mesophase 
was used instead of the detergent solution. It has been shown that lipid cubic phase 
reproduces the lateral pressure that the protein undergoes a natural membrane, resulting in 
less conformational freedom of the protein [82]. 
The most used lipid for in meso crystallization at the moment is unsaturated 
monoglycerol monooleoyl (C18:1c9; MO). When mixed with water it forms a variety of 
phase forms described on the Figure 1.14. In the process of in meso crystallization the protein 
solution is mixed with MO and the cubic phase is formed [1] (Figure 1.14). Normally, such 
solutions contain a lot of detergent coming from solubilization and purification processes. It is 
a well established fact that such additives as detergents can influence the lipid phase, change 
its properties, disturb or disrupt it. M. Caffrey with his colleagues have studied phase behavior 
after addition of various detergents [83]. The phase identification was done through SAXS 
measurements in the conditions identical to that of crystallization trials. The study has proved 
that addition of small quantities of detergents (glucopyranosides, dodecylmaltopyranosides, 
fos-cholines, CYMAL) has minimal or no effect on the phase stability. Larger amounts of 
detergents transferred the system into lamellar phase. 
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Figure 1.13 Type I and type II of membrane protein crystals. 
Type I is a stack of 2-D crystals where proteins interact with each 
other mainly by their hydrophobic surfaces. These crystals are 
usually formed by methods using lipid environments, i. e. 
bicelles, vesicles and in meso methods. Type II crystals are 
formed by interactions of polar hydrophilic areas of proteins that 
are outreaching detergent micelles in case of in surfo method. 
From [84]. 
 
LCP crystallization methodology was much upgraded within past few years by 
introducing phase preparation devices like a syringe mixer and 96-well sandwich plates. 
Consumption of protein and lipid for the crystallization trial has considerably reduced (up to 1 
mg of protein per full sparse screening of conditions), and the whole process was much eased 
by introduction of robotic systems. A robot can typically dispense down to 20 nL of LCP per 
one crystallization trial and takes 5–10 min to setup a 96-well sandwich plate [85].  
 
 
Figure 1.14 A simplified temperature-composition phase diagram for the lipid (monooleoyl) / water system 
with schematic representation of the various phases. From [78,86]. 
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2. Materials and Methods 
2.1. Materials and Equipment 
Filters: 
SFCA Bottle Top Filters, 150 mL, 0.22 µm pore size  Nalgene 
Ultrafiltration and concentration: 
Amicon
®
 Ultra centrifugal filter units Ultracel
®
- 30K  Millipore, USA  Amicon
®
 
Ultra centrifugal filter units Ultracel
®
- 50K    Millipore, USA 
Columns: 
Glass Econo-Column
®
      Bio-Rad, USA 
NAP
TM
-5 Columns       GE Healthcare, USA 
Membranes: 
Nitrocellulose Membranes (pore size 0.45 µm)   Bio-Rad, USA 
Dialysis membrane Spectra/Por
®
 MWCO 12-14,000  Spectrum Laboratories, 
USA 
Crystallization tools: 
Gastight syringes       Hamilton (Reno, USA)
  
LCP sandwich set       Paul Marienfeld GmbH 
(Lauda-Königshofen, Germany) 
 
Detergents 
 n-Dodecyl β-D-maltoside 
n-Dodecyl β-D-maltoside was used from Anatrace, Cleveland, USA distributed by 
Affymetrix, High Wycombe, UK; Purity >99% (HPLC); alpha isomer <2%, nonionic 
detergent for membrane protein stabilization and crystallization 
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Molecular formula: C24H46O11   Molecular weight: 510.6 g/mol 
CMC (H2O): ~ 0.17 mM (0.0087%) 
CMC (0.2 M NaCl): ~ 0.12 mM 
Aggregation Number (H2O): ~ 78-149 
dn/dc (H2O):   0.1435 mL/gm 
Micelle Size: 72 KDa 
Purity: ≥ 99% by HPLC analysis. 
Percent alpha: < 2 (HPLC) 
Percent dodecanol: < 0.005 (HPLC)  
pH (1% solution): 5-8 
Solubility in water at 0-5°C: ≥ 20% 
Conductance (10% solution): < 40 μS 
 n-Decyl β-D-maltoside 
n-Decyl β-D-maltoside was used from Anatrace, Cleveland, USA distributed by 
Affymetrix, High Wycombe, UK; Purity >99% (HPLC); alpha isomer <2%, nonionic 
detergent for functional purification and crystallization of membrane protein 
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Molecular Formula: C22H42O11   Molecular Weight: 482.6 g/mol 
CMC (H2O): ~ 1.8 mM (0.087%) 
CMC (0.15M NaCl): ~ 1.8 mM 
Aggregation Number (H2O): ~ 69 
dn/dc (H2O):  0.1473 mL/gm 
Purity: ≥99% by HPLC analysis. 
Percent alpha: < 2 (HPLC)  
Percent decanol: < 0.005 (HPLC) 
pH (1% solution): 5-8 
Solubility in water at 0-5°C: ≥ 20% 
Conductance (10% solution): < 40 μS 
 Monoolein (1-oleoyl-rac-glycerol) 
Monoolein was used from NU-CHEK Prep, Inc., Elysian, USA, Purity >99% 
 
 
Chemical Name: MONOOLEIN 
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Synonyms: Aldo MO; Aldo HMO;MONOLEIN; MONOOLEIN; Mazol GMO; 1-
MONOLEIN; Capmul GMO; Kessco GMO; 1-MONOOLEIN; Ablunol GMO 
Molecular Formula: C21H40O4 
Formula Weight: 356.54 
Melting point:  35-37 °C 
Other chemicals 
Acetic acid        Applichem 
Agar, bacteriological grade       MP Biochemicals 
Aluminum chloride hexahydrate      Molekula  
Ammonium sulfate       Merck  
Ampicillin        Applichem 
Ammonium persulfate (APS)     Merck 
L-(+)-arabinose       Merck/Alfa Aesar 
Boric acid        Merck  
Bromophenol blue       Merck  
Calcium chloride dihydrate      Merck 
Cobalt(II) chloride hexahydrate      Alfa-Aesar 
Complete
TM
 EDTA free      Roche  
Coomassie™, Brilliant Blue R250     Merck 
Coomassie™, Brilliant Blue G250     Merck  
Copper(II) chloride dihydrate      Merck  
Dithiothreitol  (DTT)      Sigma   
Ethanol 96%        Roth   
Ethylenediaminetetraacetic acid (EDTA)  
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di-sodium salt dihydrate      Applichem 
Glucose        Applichem 
L-Glutamic acid sodium salt hydrate     Sigma 
Glycerol        Applichem 
Glycine        Merck  
HEPES        Merck  
Hydrochloric acid       Merck  
Imidazole        Sigma  
Iron(II) sulfate heptahydrate      Merck  
Magnesium sulfate heptahydrate     Merck  
Manganese(II) sulfate hydrate      Merck  
Methanol        Roth 
Milk powder        Roth 
Monovacenin        Nu-Chek-Prep 
Phosphoric acid       Applichem 
Polyethoxyethanol sorbitan monolaurate (Tween 20)  Sigma 
Potassium hydrogen phosphate monobasic    Applichem 
Rotiphorese™ Gel 30 (Acrylamide-Solution)   Roth 
Sodium azide        Merck 
Sodium chloride       Merck 
Sodium dodecyl sulfate (SDS)     Caelo 
Sodium hydrogen phosphate dihydrate dibasic   Applichem 
Sodium hydroxide       Applichem 
Sodium molybdate dihydrate      Sigma 
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Streptomycin        Applichem 
Sucrose        Merck  
Sulfuric acid        Merck  
Tetramethylethylenediamine (TEMED)    Merck 
Trichloroacetic acid       Merck 
Tris HCl        Sigma 
Trizma Base        Sigma 
Tryptone        Applichem 
Yeast extract        Applichem 
Reagents 
 Molecular weight standard for electrophoresis:  
Page Ruler
TM
 prestained protein-ladder, Fermentas 
 Standard reagent for western blot: 
1-Step
TM 
NBT/BCIP, Thermo Scientific, USA 
 Column-material for chromatography: 
Ni-NTA-Agarose, Qiagen, Germany 
Lipids for crystallization: 
 E.coli polar lipid extract, Avanti Polar Lipids, USA 
Crystallization kits: 
 MemStart™, Molecular Dimensions, UK 
 MemSys™, Molecular Dimensions, UK  
 MemGold™, Molecular Dimensions, UK 
 MemPlus™, Molecular Dimensions, UK 
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 NeXtal Cubic Phase I Suite, Qiagen, Germany 
 NeXtal Cubic Phase II Suite, Qiagen, Germany  
 NeXtal PEGs Suite, Qiagen, Germany 
 NeXtal MemClass Suite, Qiagen, Germany 
 Cubic™, Emerald Biosystems, USA  
 Wizard I/II, Emerald Biosystems, USA 
 Wizard III/IV, Emerald Biosystems, USA 
Equipment 
Incubator      Incu-Line, VWR, Germany 
Orbital shaker      Multitron, Infors, Switzerland 
Microfluidizer     M 110P, Microfluidics, USA  
French
® 
Press apparatus    Sim Aminco, USA  
Roller Mixer      SRT6D, Stuart, UK 
Spectrophotometer     V-1200, VWR, Germany 
Peristaltic pump      SqiQ 400, Watson-Marlow, Canada  
Thermomixer      Comfort, Eppendorf, Germany  
Membrane pump      MZ 2C NT, VWR, Germany 
Power supply      EPS 301, GE Healthcare, USA  
Gyro-rocker      SSL3, Stuart, UK 
Scanner      Epson Perfection V750 Pro, Japan 
Äkta prime plus     GE Healthcare, USA  
Mini Trans-Blot Electrophoretic Transfer Cell Bio-Rad, USA 
SE 250 Mighty Small II 10×8 cm Basic Unit  Hoefer, USA 
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FTIR spectrophotometer    Vertex 70, Bruker Optics, Germany 
UV-Vis-Spectrophotometer    UV-2450, Shimadzu, Japan 
Centrifuges      Optima L90K Ultracentrifuge  
       with Rotor Ti70, Beckman, Canada  
Avanti J26 XP, Beckman, Canada 
 Megafuge, Thermo, USA 
High throughput membrane protein crystallization platform 
Robot for in meso membrane protein crystallization, automated system for imaging 
crystallization probes, UV microscope for visualization of protein crystals, temperature 
controlled storing boxes for crystallization probes.  
NT 8 Crystallography   Formulatrix, USA  
Rock Imager 1000    Formulatrix, USA 
 
Figure 2.1 The in meso crystallization robot Formulatrix NT8. The NT8 is a nanoliter-volume liquid handler 
with drop dispensing capability. The 8-tip head can aspirate and dispense drops from 100 nL to 1.8 μL. 
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2.2. Molecular biology methods 
2.2.1. Plasmid DNA isolation 
The commercial NucleoSpin® Plasmid method was used for isolation of plasmid 
DNA. The pelleted bacteria were resuspended in Buffer A1 and plasmid DNA was liberated 
from the E. coli host cells by SDS / alkaline lysis (Buffer A2). Buffer A3 was used for 
neutralization of the resulting lysate and created appropriate conditions for binding of plasmid 
DNA to the silica membrane of the NucleoSpin® Plasmid Column. Precipitated protein, 
genomic DNA and cell debris were then pelleted by a centrifugation step. The supernatant 
was loaded onto a column. Contaminations like salts, metabolites and soluble macromolecular 
cellular components were removed by washing with ethanol Buffer A4. Pure plasmid DNA 
was ﬁnally eluted under low ionic strength conditions with slightly alkaline Buffer AE (5 mM 
Tris / HCl, pH 8.5).  
2.2.2. Amplification of DNA  
DNA fragments were amplified with Polymerase Chain Reaction (PCR) [87]. 
Normally, a 20 µl reaction mix contained 20 ng of DNA matrix, 25 pmol of each primer, 5 
nmol of each dNTP’s and 0.5 U Phire® Hot Start DNA Polymerase (Fermentas). The 
amplification of DNA in the thermocycler was done with “Hot-start”-PCR in two-step 
manner. In the first step, 5 cycles of following conditions were made: 1) 15 s at 95°C, 2) 30 s 
at -3 to -5 degrees below primers’ melting temperature and 3) 40-120 s (depending on the 
length of elongated DNA fragment), elongation stage at 72° C. In the second step, 25-30 
cycles of following conditions were made: 1) 15 s at 95°C, 2) 30 s at primers’ melting 
temperature and 3) the same time as in step 1, elongation stage at 72° C. Point mutations were 
also made with PCR [88].  
2.2.3. Analysis and extraction of DNA from agarose gels  
 A horizontal gel-electrophoresis was used for analysis and extraction of DNA from 
agarose gels. The DNA probes in TAE buffer (Tris-base 2M, EDTA 50 mM and acetic acid 
till pH reaches 7.6) were applied to the 1-2% agarose gel running in TAE buffer. Staining of 
DNA bands was done by adding GelRed (Biotium) in 1:10000 dilution to TAE buffer. The 
DNA fragments were separated by applying 4 V/cm voltage to the gel. After cutting out of the 
band of interest, the Gel-Extractions-Kit (Qiagen, Hilden, Germany) was used for DNA 
extraction. 
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2.2.4. DNA restriction 
DNA fragments were cut with corresponding restriction enzymes by 1 h incubation at 
37° C. In most cases FastDigest® restriction enzymes from Fermentas were used together 
with FastDigest® buffer.  
2.2.5. Ligation of DNA 
Ligation of DNA fragments was done by incubation with T4-DNA ligase. 100 ng of 
cut plasmid DNA were taken together with 5-10X excess of insert DNA and 1 U of T4-DNA 
ligase with ligase buffer to total volume of 20 µl. Ligation mix was incubated overnight at 
RT. Deactivation of T4-ligase was done by incubation at 65° C for 10 min.  
2.2.6. Transformation of plasmids into E. coli cells 
Transformation of DNA was done into chemically-induced competent cells[89]. To 
prepare competent E. coli cells, a culture in 250 ml of SOB (SOB: 2% Bacto-trypton, 0.5% 
Bacto-yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 mM MgSO4) medium 
was incubated in a 2-liter flask at 18 C with vigorous shaking until an absorption at 260 nm 
equal to 0.6 was reached. Then, the broth was kept on ice for 10 min. Isolation of cells was 
achieved by spinning at 3000xg for 10 min at 4° C. The pellet was resuspended in 80 ml of 
ice-cold TB and kept in an ice-water bath for 10 min. The cells were pelleted by spinning as 
above. The pellet was resuspended in 20 ml of TB (10 mM Hepes, 55 mM MnCl2, 15 mM 
CaCl2 and 250 mM KCl). DMSO was added with gentle swirling to a final concentration of 
7%. The centrifugation bottle was additionally kept in ice-water bath for 10 min. 
At this point the cells became competent. They were dispensed by 100 µl into 
microfuge tubes and frozen immediately in liquid nitrogen. The frozen competent cells were 
stored at -80° C. 
For transformation a plasmid solution (< 5 ul) was added and kept on ice for 30 min. 
Then the heat shock was applied at 42 C for 1 minute without agitation. After that the cells 
were transfer onto ice for additional 15 min. 
To allow bacteria to acquire antibiotic resistance, the cells were incubated at 37° C for 
1 hr in 800 µl of SOC (Add 1/100 vol. of filter-sterilized 2M glucose to SOB) medium. 
Bacteria were stroke on plates containing appropriate antibiotics. The plates were incubated 
overnight at 37° C. 
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2.3. Heterologous expression and purification of SRII in E. 
coli 
Day 1 
Buffer A: 150 mM NaCl, 50 mM Na-Pi (mixture of Na2HPO4 and 
NaH2PO4), 2 mM EDTA pH8.0 
Solubilization buffer: 300 mM NaCl, 50 mM NaPi pH 8.0, 2% DDM 
Starting with 30g of cells 
1) 130 ml of Buffer A was added. Stirring 3-4h, 500 rpm, 4°C in darkness 
2) Homogenization and addition of DNAse 
3) French press 
a. French press cell was precooled 
b. After installation the French press cell was washed with buffer 
c. Pressure during cell lysis was kept between 900-1200 psi 
4) Centrifugation 35000 rpm, 1h, 4°C 
a. Supernatant was discarded 
b. Pellets were solubilized in 2% DDM 
5) Solubilization 
The pellets were mixed with 150 ml Solubilization buffer 
Stirring in darkness overnight at 500 rpm, 4°C 
Day 2 
Buffer B: 300 mM NaCl, 50 mM NaPi pH 8.0, 0.05% DDM 
Washing buffer: 300 mM NaCl, 50 mM NaPi pH 8.0, 30 mM imidazole, 0.05% DDM 
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Elution buffer:  300 mM NaCl, 50 mM NaPi pH 8.0, 200 mM imidazole, 0.05% 
DDM 
1) Centrifugation 35000 rpm, 1h, 4°C 
Supernatant contains protein, pellets are waste. 
2) Binding SR-II on Ni-NTA 
a. 10-15 ml of Ni-NTA were filled into glass column 
b. The resin was washed several times with H2O to remove ethanol 
c. The resin was washed 2 times with 2x column volume of buffer B 
d. Supernatant was loaded on Ni-NTA 
3) Washing 
After the protein was bound on Ni-NTA, it was washed with 500 ml of Washing 
buffer 
4) Elution 
The protein was eluted with Elution buffer. End volume was 20-25 ml. 
Day 3 
Buffer C: 10 mM Tris pH 8.0, 0.1% DDM 
Buffer D: 30 mM NaCl, 10 mM Tris pH 8.0, 0.1% DDM 
Buffer E: 500 mM NaCl, 10 mM Tris pH 8.0, 0.1% DDM 
1) The eluate from the last step is diluted 1 to 10 with Buffer C. 
2) Loading on the column 
a. The column was filled with fresh DEAE resin (15 ml). 
b. Resin was washed with H2O till ethanol was removed. 
c. Resin was wash with 2x resin volume of Buffer C. 
d. The protein was loaded on DEAE 
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3) Washing  
Resin was washed with 500 ml of the Buffer D 
4) Elution 
Protein was eluted with buffer E. 
The wings of the elution peak were cut to ensure high protein quality. 
5) The absorption spectrum of the protein was measured  
6) The protein was shock-frozen and stored at -80° C. 
2.4. Heterologous expression and purification of truncated 
HtrII in E. coli 
Day 1 
For expression in 4.5 L scale 250 ml overnight culture (250 ml LB, 0.25 ml 100 g/l 
ampicillin) were mixed with 20 µl of pre-culture (in 20% glycerol) and incubated overnight at 
37° C and 150 rpm. 
1L LB medium: 
10 g NaCl 
10 g peptone or tryptone 
5 g yeast extract 
pH 7.2 
Day 2: Expression 
6 x 2l cultures (12 l LB, 12 ml 100 g/l ampicillin) in 5 l buffled flasks were inoculated 
with overnight culture to cell density at OD(600)=0.1 and incubated at 37° C and 130 rpm. 
The addition of 0.5 mM IPTG at OD(600)=0.8-1.0 induced expression and incubation was 
continued at 37° C and 150 rpm. Cells were harvested after 3 hours, washed in approximately 
100-150 ml cell washing buffer (150 mM NaCl, 25 mM NaPi, 2 mM EDTA pH 8.0) and then 
resuspended in the same buffer, 5 ml per gram of cells. Then the cells were lysed using a 
microfluidizer with 900 KPa pressure. Membrane components were separated immediately by 
centrifugation (45 Ti rotor, 45 000 rpm, 4° C, 1h). Supernatant was discarded and the 
obtained pellet homogenized (5 ml per gram cells) in solubilization buffer (300 mM NaCl, 50 
mM Na-Pi, 2% DDM pH 8.0) and moderately stirred at 4° C. 
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Day 3: Purification 
Buffer 1:  50 mM Tris pH 8.0 
   100 mM NaCl 
   0.1% DDM 
Buffer 2: 50 mM Tris pH 8.0 
   100 mM NaCl 
   0.1% DDM 
   250 mM Mesna or 100 mM DTT 
Insoluble components were removed by centrifugation (45Ti or 70Ti rotor, 45 000 
rpm, 4° C, 1h). The clear supernatant was loaded on a 20 ml Chitin-Beads column 
equilibrated in Buffer 1. After the washing step with Buffer 1, 20 ml of buffer 2 were added to 
the chitin beads and stirred overnight at 4° C. 
Day 4 
The suspension was filtered, the eluate was concentrated and dialysed against the 
buffer containing 150 mM NaCl, 20 mM Tris pH8.0, 0.1% DDM. 
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2.5. Biophysical methods for protein properties determination.  
2.5.1. SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and western- 
blotting (WB) 
The denaturing SDS-polyacrylamide gel electrophoresis was performed (SDS-PAGE) 
by the method of H. Schägger and G. Jagow [90] for the analysis of proteins. For this purpose, 
SDS sample buffer (120 mM Tris pH 8.0, 6% (w/v) SDS, 35% (w/v) glycerol, 0.05 (w/v 
bromophenol blue) was added to the protein samples in a volume equivalent, shaken for 15 
min and applied to 0.75 mm to 1 mm thick, 12-15% acrylamide gels. The separation of the 
proteins was carried out by applying an external voltage of 120 V (anode buffer: 200 mM 
Tris/HCl, pH 8.9; cathode buffer: 100 mM Tris/HCl, 100 mM Tricine, 0.1% (w/v) SDS, pH 
8.25, the detection of the protein bands were visualized by staining the gel with Coomassie 
Brilliant Blue R250 (staining solution: 0.1% (w/v) Coomassie Brilliant Blue R250, 10% (v/v) 
acetic acid, 5% (v/v) methanol, destaining: 10% (v/v) acetic acid, 5% (v/v) methanol).  
After separation by SDS-PAGE proteins were transferred to PVDF membrane 
(Macherey-Nagel, Düren) with a semidry blotter (30 min at 1.2 mA/cm2) (Anode buffer: 300 
mM Tris/HCl, 100 mM Tricine, pH 8.7-8.8; Cathode buffer. 30 mM Tris/HCl, 300 mM 6-
amino-n-caproic acid, pH 8.6-8.7, the membrane was incubated with 5% (w/v) dry milk in 
TBS buffer (5 mM Tris/HCl, 15 mM NaCl, pH 7.5) and blocked with the corresponding 
antibodies according to the manufacturer (1st antibody mouse anti-His IgG (Sigma), 2nd 
antibody goat anti-mouse IgG-Alkaline Phosphatase (Boehringer Mannheim). Visualization 
was done by adding NBT/BCIP solution (Pierce) that yields an intense, insoluble black-purple 
precipitate when reacted with alkaline phosphatases. 
2.5.2. Size-exclusion chromatography (SEC) 
Size exclusion chromatography is the commonly used experimental lab technique to 
separate proteins based on their molecular weight [91].  ÄKTA Prime purification system 
was used for automatic Ni-NTA purification and size-exclusion chromatography (SEC). 
Superose 6pg was used as a matrix for SEC analysis. After column packing, it was calibrated 
with a set of proteins that were purchased from commercial suppliers and for which the 
molecular mass was known. These experiments resulted into calibration curves shown below.  
Vo – void volume 
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Ve – elution volume 
Vc – column volume  
Kd = 
     
     
  [92]  
Standards Mw, Da lg(Mw) Kd Ve, ml Ve/V0 nm (DLS) lg(nm) 
Vt=       177,60       
Aceton 58 1,76 1,00 177,58 2,65     
UMP 324 2,51 0,90 166,00 2,48     
CytC 12400 4,09 0,92 168,43 2,51 1,80 0,26 
RNAse A1 13700 4,14 0,84 159,65 2,38 2,10 0,32 
CA 29000 4,46 0,74 149,21 2,23 2,60 0,41 
bLAG-B 18400 4,26 0,73 148,15 2,21 2,90 0,46 
OVA 44000 4,64 0,68 142,45 2,13 3,10 0,49 
BSA 66000 4,82 0,62 135,57 2,02 3,70 0,57 
ADH 150000 5,18 0,59 132,33 1,98 3,60 0,66 
bAmylase 200000 5,30 0,55 127,33 1,90 5,90 0,77 
Ferritin, 
pIV 443000 5,65 0,50 121,90 1,82 6,90 0,84 
TGN 660000 5,82 0,41 112,20 1,67 8,70 0,94 
Ferritin, pIII 886000 5,95 0,40 111,50 1,66 9,40 0,97 
BD, peakI 9960000 7,00 0,07 74,50 1,11 44,10 1,64 
Ferritin, 
peak I 
3200000
0 7,51 0,06 73,28 1,09 50,10 1,70 
V0=       67,00       
 
Based on elution volumes of standards, two calibration curves were built. The first one 
(Figure 2.2) is showing logarithm of the particle size vs. Ve/Vo. The particle size was 
determined by dynamic light scattering. The linear approximation is quite good in the whole 
range. The next graph (Figure 2.3) is representing Kd vs. lg(MW). It was used for 
determination of the molecular weight of the eluted protein. It is clear that linear fit can be 
built only for 4<lg(MW)<6. Since the physics of the separation process is based on the 
difference in size of the particles it is expectable that the size of the protein can be determined 
more precisely than the molecular weight. This fact can lead to problems when analyzing 
elution spectrums, especially in case of membrane proteins where detergent micelles are the 
main factor influencing on the size of solubilized protein and the size depends on the type of 
detergent.  
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Figure 2.2 Calibration curve lg(particle size) vs. Ve/Vo 
 
Figure 2.3 Calibration curve Kd vs. lg(molecular weight) 
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2.5.3. Mass-spectrometry (MALDI-TOF) 
Matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-
TOF MS) is a relatively novel method for protein identification in which a co-precipitate of an 
UV-light absorbing matrix and a biomolecule is irradiated by a nanosecond laser pulse 
[93,94]. The vast majority of commercial MALDI mass spectrometers use a nitrogen laser 
with a wavelength of 337 nm and a pulse duration of ~ 10
-9
 sec. The matrix must have 
properties that provide reduced destructive properties of the laser radiation and the effect of 
the emergence of the so-called "soft" ionization without significant fragmentation of the 
analyte. Most of the laser energy is absorbed by the matrix, which prevents unwanted 
degradation of the protein. The ionized biomolecules fused with the matrix are accelerated in 
an electric field of the device and enter the flight tube. During the flight in the tube of the 
mass spectrometer, different proteins are separated according to their mass-to-charge ratio and 
come to the detector at certain times. This is the way to separate and distinguish chemically 
different proteins. 
Mass spectrometric analysis of membrane proteins by MALDI-TOF was carried out 
on pure protein solutions and on PAGE gel extractions. Trypsin-digested samples were 
extracted from the gel, concentrated and desalted using Zip-Tip C18 columns using standard 
protocol.  
Solutions: 
1. Wetting solution - 50:50 acetonitrile (ACN) : water (H2O)  
2. Sample preparation - 0.1% trifluoroacetic acid (TFA) in H2O pH <4  
3. Equilibration solution - 0.1% TFA in H2O  
4. Wash solution - 0.1% TFA in H2O  
5. Elution solution - 0.1% TFA in 50:50 ACN:H2O 
2.6. Crystallization of the SRII/HtrII complex 
Starting material 
1) NpSRII-His, C = 2-3 mg/ml; p.r< 1.3 
2) NpHtrII-135, C = 2-3 mg/ml  
3) Polar lipids of purple membranes 
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Procedure 
Day 1 (Reconstitution) 
1) Proteins were mixed at room temperature (1:1 molar ratio) 
2) Incubated for 30 minutes at room temperature 
3) Added NaCl to final concentration 150 mM 
4) Added PM lipids (1:1 (wt:wt) lipid:protein ratio) 
5) Added biobeads (10-20% of total volume) 
6) Protein/lipid solution was shaken at 4° C in darkness overnight  
Day 2 
1) Reconstitution test 
Centrifugation of 400 µl of solution 14 000 rpm for 10 minutes. If supernatant 
turns colorless then the reconstitution was successful. 
2) Removed biobeads 
3) Centrifugation 24 000 rpm, 40 minutes, 4° C, rotor Ti70 
4) Removed supernatant 
Resolubilization 
Buffer: 150 mM NaCl, 25 mM NaKPi pH 5.1, 2% OG 
Volume was calculated with respect to the final protein concentration    0.6 mg/ml. 
1) Resuspended the pellet by gentle stirring at 4° C. 
2) Transferred to 50 ml Falcon tube 
3) Shook at 4° C in darkness 
4) Centrifugation 1h, 35 000 rpm, 4° C, Ti70 
The solubilized protein must be in supernatant. 
Cubic phase preparation 
Detergent OG was added to the protein solution till the aimed concentration is 
achieved. Detergent concentration was checked by IR spectroscopy. The protein solution was 
added to monooleoyl in a ratio 1:1 (vol:vol) and several passes through interconnected 
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syringes for cubic phase preparation were performed. Cubic phase was ready for usage after 
1-2 days. 
2.7. Treatment of the X-Ray diffraction data 
2.7.1. Determination of twinning fraction  
To determine the factors of twinning diffraction data from 4 diffraction images was 
integrated in the program MOSFLM and Scaled in SCALA [95,96]. As a result, a few 
hundred reflexes related by twinning law were obtained. Twinning factor determined from the 
statistical analysis of the distribution of intensities of the reflections, using Britton plot [97] 
and the Yeates statistics [98], implemented in the program DETWIN [99], as well as the 
Internet resource  University of California in Los Angeles 
(http://nihserver.mbi.ucla.edu/Twinning). Twin factors determined by various methods agree 
with each other within 5%. These methods have been used previously to determine the factors 
of twinning crystals BR [100], and it was demonstrated that the twinning factor, calculated 
from several hundred reflections, equal to the value determined from the full set of diffraction 
data measured from the same crystal. The quality of the diffraction of crystals and their 
twinning factor was used in deciding which of the crystals was used in further experiments at 
the synchrotron radiation source [101]. 
2.7.2. Determination of phases by molecular replacement  
The term “molecular replacement” (MR) is usually used to describe the utilization of 
the structure of highly homologous protein to solve the unknown crystal structure of a target 
protein. MR enables the determination of the crystallographic phases by giving initial 
estimates of the phases of the new target structure from a previously solved structure. This 
method is opposed to the other main methods for solving the phase problem: experimental 
methods (which measure the phase from isomorphous or anomalous differences) or direct 
methods (which use mathematical relationships between reflections to derive a phase set for 
all reflections from phases for a small or set of reflections). The use of MR is now becoming 
more common as the data base of known structures expands. This method is especially helpful 
when the structures of protein families are solved, for instance, GPCR receptors.  About 70% 
of the deposited macromolecular structures these days were solved using MR and at its best 
has the advantages of being quick and highly automated [102]. 
 53 
 
In case of the unit cell that contains more than one molecule, the best way to compare 
the diffraction patterns and to determine protein orientation is the usage of Patterson 
functions. Any Patterson function contains a set of peaks representing intramolecular vectors. 
For every molecule orientation found in the unit cell a single set of vectors will be found. The 
peaks of the set of intramolecular vectors should be within the biggest intramolecular distance 
r from the Patterson function origin. Contrary, the intermolecular vectors should be, in 
general, longer than intramolecular. They can be called a system of cross-vectors. The 
respective orientation of the molecules can be determined by comparing intramolecular 
Patterson functions inside the sphere with radius r [103].   
Model orientation in the process of molecular replacement can be split in two steps: 
rotation search and translation search. 
Rotational search 
In the observed Patterson map  peaks arising from different types of inter-atomic 
vectors are present. However, the model Patterson map doesn’t contain all types of the peaks 
at the stage of the rotation search. Any inter-atomic vectors arising from non-crystallographic 
symmetry or from other molecules of a different type are not taken into account as normally 
only one search molecule is used at a time. Moreover, the translations that move the model 
molecule to the correct position with respect to the rotational symmetry operations are not 
known and the inter-atomic vectors arising from this symmetry are typically ignored. By 
default, the search molecule is placed in a P1 unit cell; in other words, the rotational 
symmetry is ignored. It is computationally most efficient to put the center of gravity of the 
model molecule to the origin of the unit cell [104]. 
The model Patterson map has only peaks arising from intra-molecular vectors and 
inter-molecular vectors between copies arising from lattice translations. The rotation search 
superimposes this `partial' Patterson map with the observed Patterson map. This can be 
imagined as a pattern-matching procedure. The search pattern is taken from the model 
Patterson map, while the observed Patterson map contains the search pattern where the 
angular orientation is unknown. In the observed Patterson map, the search pattern is 
concealed by other patterns that are not taken into account in the model Patterson and noise 
[104]. 
The rotation function is then given by: 
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R=               X1, 
for the Patterson P1 and the rotated Patterson P2 within the volume U. This will have a 
maximum value when the two self-vector sets are equivalently oriented. 
Translation search 
By the analogy with the rotation function the translation function can be introduced by 
T(t)=             X1, 
The maximum of this function finds the best fit of the computed and correctly oriented 
cross-Patterson P(u, t) with the Patterson P(u). In the case of several copies of the subunits 
present in the unit cell one can position each of them step by step [105].  
2.7.3. Model building and refinement 
X-ray data quality was assessed using phenix.xtriage [106]. Starting from a molecular 
replacement solution from Molrep [107],  using PDB entry 1H2S as a template, the structures 
were initially automatically built in Arp/Warp [108],  refined in Refmac5 [109] and the final 
steps of refinement were done in Phenix [110]. The structures were validated using 
MolProbity [111].  
2.7.4. Obtaining the structures of intermediate states  
The structures of intermediate states were obtained by exploiting the same procedure 
as in [6]. Difference density maps ∆ρ = (|Fill| - |FGobs|)exp(iφG) were used to reveal major 
structural changes that occurred after illumination of the crystals, where |Fill| - the observed 
amplitudes from illuminated crystals, |FGobs| - the observed ground-state amplitudes and φG 
are the phases calculated from the ground-state model. Refinements of intermediate states 
were performed by starting with a superposition of a fixed and a unfixed ground-state 
structure with occupancies varying in the range 0.2–0.8 by simulating annealing (using 3,000 
and 5,000 K and a slow cooling protocol in CNS [112]). Extrapolated densities were 
calculated for refined models ρex = (1 - α)|FG|[exp(iφG)] + α|FM|[exp(iφM)] with different 
occupancies α for the intermediate state. Intermediate state occupancies were estimated from 
the best correlation as 50 ± 10% for late M state. This variation had no significant effect on 
the conformation for the intermediate state after refinement. After occupancy had been fixed, 
models were further refined and manually rebuilt in program Coot until convergence 
of R factors was reached [6]. 
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3. Results and Discussion 
3.1. Overall characteristic of the ground state structure of the 
SRII/HtrII complex 
The structure of the complex of SRII-D75N mutant has revealed features that were not 
present in the structure of the wild type complex (see Chapter 3.2). The new quaternary 
structure of the complex was crystallized in the I212121 space group, while all the previous 
structures of the complex were crystallized in P21212. The influence of crystallization 
conditions has changed not only the space group of crystals but also the angle between 
protomers. The dramatic difference in the structures in two space groups may have a big 
influence on our understanding of the signal transduction mechanism in the SRII/HtrII 
complex. In order to check, whether the new shape of the complex is an effect of the new 
crystallization conditions or of the D75N mutation itself, we have crystallized the wild type 
complex. The ground and intermediate state structures were solved. These structures have 
shown the same respective orientation of SRII and HtrII as in the case of the mutation D75N. 
Moreover, the changes in the structure upon transition from the ground state to the M state 
were the same. In this chapter the ground state structure of the wild type complex SRII/HtrII 
in the I212121 space group will be discussed. 
 
Figure 3.1 Structural multi-domain organization of the SRII/HtrII complex. The functional complex consists 
of two membrane proteins SRII and HtrII forming αββα topology, where two HtrII molecules are flanked by 
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two SRII light receptors. HtrII is organized as a sequence of domains that are conserved among histidine 
kinases: transmembrane domain, HAMP domain, adaptation domain, kinase domain. The red rectangle 
indicates the part of the complex that was crystallized. A-G, TM1 and TM2 are the transmembrane helices, 
and AS1 and AS2 are the helices of the HAMP domain. 
The functional complex of membrane proteins SRII and HtrII is a homodimer, consists 
of two SRII molecules and two HtrII molecules. SRII contains 7 transmembrane α-helices 
named from A to G and HtrII contains two transmembrane α-helices named TM1 and TM2. 
As was mentioned before, HtrII comprises a membrane part and very elongated coiled-coil 
cytoplasmic part. This anisotropic geometry of the complex makes the formation of well-
diffracting crystals from intact proteins very improbable (see Figure 3.1). The length of HtrII 
in the direction perpendicular to the membrane is about 250 Å that considerably exceeds the 
typical distance between layers in crystals grown from cubic phase. Therefore, truncated 
constructs of HtrII were crystallized in complex with SRII. These constructs contain the 
water-soluble N-terminus (amino acids 1-22), membrane part of HtrII (amino acids 23-82) 
and the first HAMP domain (amino acids 83-135). Previously published structures of the 
complex contained HtrII truncated at position 114 ([7], PDB code 1H2S) and 157 ([6], PDB 
code 2F95). 
 
Figure 3.2 The crystal of the SRII/HtrII-157 complex 
in a cryoloop. The crystal belongs to I212121 space 
group. Datasets were collected on macromolecular 
beamlines of ESRF in Grenoble: ID23-1, ID14-1, 
ID14-2, ID-29. 
 
In an intensive crystallization screen we obtained two new crystal forms (Figure 3.2) 
of the SRII/HtrII complex displaying space groups with I212121 and P64 symmetry  in 
contrast to P21212 published before  ([6,7], PDB codes 1H2S, 2F95). In the case of the 
I212121 space group the resolution for the both ground and M states was 1.9 Å. In this case 
HtrII was truncated at the position 157 and contained a 6xHis tag. Aiming to resolve the 
structure of the HAMP domain, the length of HtrII construct was truncated to 135 amino acids 
(discussed below). This complex was crystallized at similar conditions and data sets of 2.5 Å 
resolution in the P64 space group were collected (for statistics see Appendix I). No 
intermediate states data was collected in this case. 
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When comparing wild type structures solved in the I212121 and P21212 space groups it 
can be seen that the overall structure SRII is nearly the same and is highly similar to the 
structure of SRII alone [113,114] (see Figure 3.3 and Figure 3.4). SRII is a seven-helix 
transmembrane protein with molecular mass of 24.7 KDa. Most of the protein was built in 
electron density maps, except 6xHis-tag containing C-terminus which couldn’t be resolved, 
probably, due to high flexibility. HtrII was truncated at the amino acid 157. This construct 
contains disordered N-terminus (amino acids 1-22), two transmembrane helices connected via 
a short extracellular loop (23-82), the first HAMP domain (83-135) and the helical linker 
between the two HAMP domains (136-157). Though the HAMP domain was present in the 
protein construct expressed, the electron densities in this region turned out to be very poor and 
discontinuous that didn’t allow structural modeling of HtrII after Gly83-Gly84.  
 
 
Figure 3.3 Overall view of the obtained structure of 
the SRII/HtrII complex. 
 
Figure 3.4 Crystal lattice of the SRII/HtrII 
complex in plane of the membrane. 
 
The structure of the HAMP domain would be a big asset to the currently available 
structures of the SRII/HtrII complex. Despite a number of experiments, neither of the data 
sets yielded electron density strong enough for building HAMP. The reasons for this problem 
can be: 
 the flexibility of TM2 helix in the point of two glycines (G83, G84),  
 thermally unstable structure of the HAMP domain,  
 unspecific interactions with neighboring proteins in the crystal, 
 protein unspecific proteolysis in course of crystallization  
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It is worth noting that the TM1 helix structure is also not complete, built only up to 
amino acid 22, approximately at the same distance from the membrane as TM2. The 
structures in the I212121 space groups contain two more amino acids on the C-terminus of 
HtrII in addition to 23-82 that were available in P21212. This additional information was very 
important for modeling of the HAMP domain structure by homology and modeling of the 
interaction between the receptor and the transducer. 
A number of hydrocarbon lipid tails were traced in the electron density (Figure 3.4). 
The interaction between proteins in the plane of the membrane is mostly mediated by these 
lipids. Modeling hydrophobic lipid tails as polycarbon chains has reduced R-factors and 
improved electron density maps considerably that was important for building of the complete 
model. The polar heads of the lipids couldn’t be resolved. 
  
Figure 3.5 Adjacent proteins in the crystal are also interacting through several hydrogen bonds. Contacts in the 
EF loop are mediated by hydrogen bonding from Ser154 to Gln151 of the symmetry mate. A and B helices have 
interactions mediated by residues Arg34 and Leu56in the polar regions. 
There are several places where adjacent proteins in the crystal form contacts. In the 
I212121 space group EF loops of the neighboring proteins appear to be close to each other 
forming 2 hydrogen bonds from Ser154 to Gln151’ (and the corresponding symmetric bond 
from Gln151 to Ser154’, see Figure 3.5) 
Strong similarity between the ground-state structure of NpSRII alone and the ground-
state structure of NpSRII in complex with NpHtrII was also observed. The RMSDs of 
coordinates are 0.53 Å for the structure in space group P21212 (PDB code 1H2S) and 0.45 Å 
for the structure in space group I212121. There are only slight differences in flexible loop 
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regions, which include also the position of the C–D loop. An important observation concerns 
D193, which occupies the same position in the structure of the complex and in the present 
structure, contrary to its position in structures 1H68 and 1JGJ. These data emphasize the 
importance of identical crystallization conditions (in detail in [113]). 
The structure of the active site is similar to that in 1H2S (Figure 3.6). The retinal 
molecule is covalently bound to Lys205 through Schiff base. The retinal is in all-trans 
isomerization state. The positive charge of the protonated Schiff base is equilibrated by the 
negative charge of the counterion Asp75. The hydrogen bonds network is organized through 
the Schiff base, Asp75, Asp210, Trp76, the water molecules W1, W2 and W3. 
 
Figure 3.6 The active center of SRII in “sticks and balls” representation. Waters are shown as red balls, 
oxygen atoms are shown in red, nitrogen atoms are shown in blue. The map is contoured with 2σ cutoff. 
In general, the structure of SRII and HtrII proteins is very similar to the structure 
obtained before in the P21212 space group. Major difference is related to the mutual 
disposition of the proteins in a dimer. The I212121 reveals a new “U”-shape of the complex 
(discussed in detail in Section 4.3). Having solved the X-ray structures of SRII and HtrII in 
different space groups we can conclude that the structure of the proteins remains the very 
similar with small RMSD regardless of crystal contacts and buffer contents. 
As it is shown on the double distance matrix between structures in P21212 and I212121 
(Figure 3.7), the largest RMSD is observed in the loop regions of SRII and on the C- and N- 
termini of HtrII. This result is very important as the position of the C-terminus affects the 
structure of the HAMP domain and it is different in the I212121 and P21212 space groups. 
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Figure 3.7 The double distance matrix plot showing differences in the ground state structure of the wild type 
complex in I212121 and P21212 space groups. Chain A corresponds to SRII, chain B corresponds to HtrII.  
3.2. The structure of the D75N mutant. Implications from the 
structure 
Isomerization of the retinal and Schiff base deprotonation are primary acts of the 
signal transduction in SRII. Asp73-to-Asn73 mutation is known to inhibit completely the 
signal transduction in SRII from H.salinarum [50] and similar Asp75-to-Asn75 mutation has 
barely any effect on the corresponding protein function in N.pharaonis [69]. Moreover, the 
corresponding mutation in other retinal proteins (like halorhodopsin, sensory rhodopsin I, and 
bacteriorhodopsin) has a drastical effect on the functionality of these proteins. Certainly, an 
explanation for the insignificance of the D75N mutation for signal transduction in the 
SRII/HtrII complex is required for probing existing paradigms of the molecular mechanisms 
of retinal protein functions. To create a molecular basis of the explanation of the fact that 
D75N mutation retains functionality of the NpSRII /NpHtrII complex, the X-ray 
crystallographic study was performed. 
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The D75N mutation was introduced into the gene by directed mutagenesis. The 
protein bearing the mutation was expressed as wild type SRII. The crystallization procedure 
was performed as for wild type complex. Crystals were fished and flash frozen directly 
without using a cryoprotectant. The X-ray data were collected at ESRF, beamline ID14-1. 
 
 
Figure 3.8 Fold of the receptor/transducer complex (side view). NpSRII-D75N/NpHtrII complex is shown in 
yellow and the wild type NpSRII/NpHtrII is shown is green. “N” and “C” letters denote N- and C-terminus of the 
proteins. The structures of receptors are overall identical, whereas some deviations were observed on the termini 
of HtrII. These deviations can be attributed to the different crystallization conditions and flexibility of the region. 
Coordinates and structure factors of NpSRII-D75N/NpHtrII have been deposited in the Protein Data Bank with 
the 4GYC accession number. 
We have obtained the NpSRII-D75N/NpHtrII mutant structure from crystals grown by 
in meso approach diffracting to 2.0 Å. The crystals were plate-like, belonging to type I [115] 
and grew up to 1200x50x20 µm (see Methods and Appendix I for crystallographic statistics). 
Each asymmetric unit contains one NpSRII-D75N/NpHtrII heterodimer; one of the 
crystallographic axes is collinear to the natural 2-fold axis between transducer molecules in 
the 2:2 dimer (Figure 3.8). The complex is “U”-shaped as in all the other structures in I212121 
and P64 space groups (see below). Receptors are oriented head-to-head, forming several 
contacts within loops. Transducers of adjacent layers in crystals are not stacked one below 
another but are rotated and displaced due to the crystallographic screw axis perpendicular to 
the membrane in the center of the dimer.  
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In the mutant state we observe several conformational features resembling the M-state 
of the wild type (Figure 3.9a). Since Asp75 residue is replaced with a neutral Asn75, it has no 
connectivity to water molecule W1 and the Schiff base. It causes rotation of Asn75 side chain 
with respect to Asp75 and a shift towards Arg72. The hydrogen bond to Thr79 is lost. Water 
molecule W3 disappears breaking additional bonds in the hydrogen bond network. Water 
molecule W2’ is moved by 0.9 Å to the Schiff base. It forms a hydrogen bond with the 
nitrogen from Asn75 resembling W2’-Asp75 bond in the M-state. Water molecule W4’ is 
shifted in the mutant towards the extracellular part by 2 Å. Thereby the salt bridge between 
Arg72 and Tyr51 is broken. There is a slight movement of Arg72 residue towards the 
extracellular part, which can be expected from the absence of the charge at Asn75. Water 
molecule W1 is 0.3 Å shifted towards the Schiff base. All these rearrangements lead to a 
distortion of the G helix backbone with the RMS deviation from the wild type for the residues 
196-206 as high as 0.12 Å with the maximum amplitude of 0.3 Å around the residue Asn201.  
 
  
Figure 3.9, Panel a: Structural differences between the ground states of NpSRII-D75N and WT in the vicinity 
of the retinal Schiff base  including water molecules,. Wild type molecule and waters (balls) are shown in 
green; NpSRII-D75N is shown in yellow. Primes denote water molecules in the wild type ground structure. 
Figure 3.9, Panel b: Structural differences between NpSRII-D75N ground state and the K-state intermediate 
in the vicinity of the retinal Schiff base including water molecules. Ground state NpSRII-D75N and waters 
(balls) are shown in yellow, the K-state and waters are shown in orange. Primes denote water molecules in the 
K-state structure. 
Figure 3.9, Panel c: Structural differences between NpSRII-D75N ground state and the M-state intermediate 
in the vicinity of the retinal Schiff base including water molecules. Ground state NpSRII-D75N and waters 
(balls) are shown in yellow, the M-state and waters are shown in magenta. Primes denote water molecules in 
the M-state structure. 
Illustrations from [116] 
 63 
 
Comparing the structure of NpSRII-D75N with those of the ground and M-state of the 
wild type receptor it is obvious that the hydrogen bond network of the mutant is still able to 
preserve global arrangement of the α-helices (Figure 3.9c). In essence, this is an indication of 
the fact that the D75N mutant is resting in the ground state and not a model of the M state of 
the wild type protein. Inspecting the hydrogen bond network more closely one observes that 
the water molecule W3 is not present in the mutant. In the ground state of the wild type it 
forms a pentagon of hydrogen bonds together with W1, Asp75, Asp201 and Schiff base. Due 
to the absence of W3 two hydrogen bonds mediated by this water molecule, one bond to 
Asp75-Oδ and the second one to W2, are absent. The disappearance of two hydrogen bonds 
weakens the connection between C and G helices. However, reducing C-G interactions is not 
sufficient to trigger the rearrangement of the helices such that an M-state like conformation is 
reached. Indeed, in the M-state of the wild type complex in addition to W3, W1 is also not 
present. Furthermore, the hydrogen bonds connecting helices C and G through water 
molecules W2 and W4 are disrupted. Interestingly, also in the K state of the wild type the 
hydrogen bonds mediated by water molecules W1 and W3 are absent (Figure 3.9b). 
Apparently, the hydrogen bond network stabilizing the ground state structure is loosened and 
resembles that of the K-state.  
Table 1. List of hydrogen bonds in the active center for different states of the comlex.  
 
NpSRII/NpHtrII 
ground state 
NpSRII-
D75N/NpHtrII 
ground state 
NpSRII/NpHtrII M-
state 
W1•••Asp75/Asn75 + + – 
W1•••Asp201 + + – 
W1•••Lys205 + + – 
W2•••Asp201 + + + 
W2•••W3 + – – 
W2•••W4 + – – 
W2•••Asp75/Asn75 – +  + 
W3•••Asp75/Asn75 + – – 
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W4•••Tyr51 + – – 
W4•••Arg72 + + + 
 
Our data allow envisioning a molecular mechanism of signal transfer from the receptor 
to the transducer. Indeed, a general fundamental fact for retinal proteins is that upon 
absorption of a photon retinal isomerizes and the hydrogen bond between Schiff base and the 
adjacent water molecule W1 is broken resulting in its disappearance from the active cites. 
Additionally, side chains of the residues in the active cite become mobile as seen from 
increased B-factors. Second, the carboxylic group of Asp75 is rotated by 90° with respect to 
its ground-state position (already partially rotated in NpSRII-D75N) thereby losing its 
connection to the water molecule W3, which becomes disordered (already absent in NpSRII-
D75N). Third, such reduction of the hydrogen bond network in the extracellular part of retinal 
pocket leads to further structural rearrangements. Indeed, water molecule W2 shifts towards 
Asp75 in the M-state of wild type NpSRII/NpHtrII complex. While in the ground state it is 
linked to water molecules W3 and W4 and to Oδ of Asp201, in the M-state only the bond to 
Asp201 remains intact. A new bond from W2 to Asp75 appears after the rotation of the side 
chain. Thus, only two hydrogen bonds are mediated through W2 in the M-state in contrast to 
three bonds in the ground state. Fourth, water molecule W4 shifts in the M-state towards the 
extracellular part by 2 Å and concomitantly breaking the hydrogen bond between W4 and 
Tyr51-OH that links Tyr51 with Arg72 (see Table 2). Finally, inter-helical connections 
between helices C and G are broken and the receptor splits in two loosely connected domains 
consisting of A, B and G α-helices and C, D, E and F, respectively. The movement of the 
helix G triggers signal propagation to the TM2 helix of the transducer.  
As was discussed above, the NpSRII D75N mutant is different from the wild type 
protein  mainly in the hydrogen bond network, which, in effect, weakens the helix C-helix G 
interaction, like it is also been observed for the structure of the K-intermediate. Apparently, in 
both insistences the protein is poised for reaching the active state. Infrared spectroscopic data 
indicated that upon its activation the conformational changes observed for the NpSRII-D75N 
mutant are almost identical to those observed for the wild type [117]. It is in line with the 
observation that this mutant displays wild type physiological behavior and gives additional 
confidence for the described above structural explanation of the unexpected consequence of 
D75N mutation. From electron paramagnetic resonance (EPR) data it was concluded that the 
D75N mutation shifts the ground state conformation of NpSRII-D75N and its cognate 
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transducer into the direction of the signaling state [118]. The present results and those from 
spectroscopic investigations could provide a reason why the corresponding HsSRII-D75N 
mutant shows constitutive activity. In this case, the neutralization of the counterion might 
trigger conformational changes large enough to stabilize the active state. Thus, our 
crystallographic data show that deprotonation of the Schiff base itself is not mandatory for the 
receptor activation. This does not mean the rest positive charge at the Schiff base does not 
influence the conformational changes since it still can interact with charges in more distant 
positions. 
Obtained crystal structure of ground state complex of NpSRII-D75N/NpHtrII in the 
crystals of the I212121 space group gives a new insight into the structure and possible 
molecular mechanisms of signal propagation of sensory rhodopsin II with its cognate 
transducer. We show the importance of the hydrogen bonds network inside SRII and propose 
a mechanism by which the energy stored in hydrogen bonds is transferred to HtrII. It should 
be stressed that these data do not contradict with the early proposed molecular mechanism of 
signal development in the membrane part of the NpSRII/NpHtrII complex [6]. In opposite, the 
present work provides its additional valuable support. 
3.3. The structure of the M state intermediate. Signal 
transduction 
An intermediate M state is important for understanding of the processes underlying 
signal transduction in SRII/HtrII complex. It was important to crystallize the signaling state in 
the same conditions as the ground state to check whether the molecular mechanism remains 
conserved. The M state structure was obtained by the procedure developed before and 
described in paper by Moukhametzianov et al. [6]. In brief, after collecting the ground state 
dataset the crystal was illuminated with the green laser for several seconds at room 
temperature. Then the crystal was flash-frozen again and the new dataset was collected from a 
different part of the crystal, from which the ground state was collected.  
Having two data sets from different space groups (I212121 and P21212) we checked 
whether different space groups have a structural influence on the retinal binding site. As can 
be seen from Figure 3.7 there are almost no differences found for the ground state structures 
(Figure 3.12a) as well as that for the activated M intermediate (Figure 3.12b) indicating that 
the different crystallization conditions and space groups have little, if any at all, influence on 
the structurally important regions of the complex. This is substantiated if one analyzes the 
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transition between ground state and the M state (Figure 3.8). In I212121 as in P21212 the retinal 
chromophore switches from all-trans conformation to 13-cis upon photon absorption and with 
Lys-Cε simultaneously shifting towards the central water cluster. The side group of Asp75 is 
rotated by about 90° from its ground state position, thereby losing the hydrogen bond to 
Thr79. Consequently, W3 becomes disordered and disappears in the M state. Hydrogen bonds 
pentagon (Asp201-Oδ···W2···W3···Arg72-Nε···W1) does not exist any longer in the M state 
because molecules W1 and W3 have vanished. Consequently, helices C and G have more 
freedom to move independently. The water molecule W2’ is located close to Asp75 and 
Arg72. Thus, the signal is generated by the retinal isomerization and then propagates to the 
interface between the receptor and the transducer. The signal propagation is driven by 
rearrangement of the hydrogen bond network mediated by the water molecules that leads to 
the movement of the receptor helices described above. The main trigger of this process is the 
loss of connectivity between C and G helices. 
One of the questions, which had to be taken with care, is weather the observed 
changes in the structure relate to real signal transduction mechanism or are just resulting from 
the radiation damage. The recent study [119] has shown that retinal isomerization and water 
molecules translocation can result from extensive X-ray illumination itself. To avoid the 
radiation damage, the exposed dose was always kept under reasonable limits and was the 
same for the ground state and the intermediate state data collection. If, nevertheless, any 
radiation damage did occur, it would be subtracted out and would not appear on difference 
Fo-Fo maps. As the data from the illuminated crystals is a superposition of ground and 
intermediate states, the Fo-Fo maps are the major experimental result to find and observe 
changes in the structure upon transition between states of the complex (Figure 3.11). 
The conformational changes observed for free NpSRII and for NpSRII in complex 
with its transducer are quite similar in nature (Figure 3.12). Major movements are observed 
for helices F and G, which have been correlated to signal propagation from the receptor to the 
transducer. Additionally, an inward movement of the extracellular part of helix C is observed. 
Although these conformational changes are detected in both cases, in the case of NpSRII 
alone, they have almost twice-as-large amplitudes. Smaller changes in the complexed NpSRII 
cannot be attributed to crystal packing, as it is looser in the crystals of NpSRII–NpHtrII, 
especially in space group I212121. Thus, it means that the transducer opposes such structural 
rearrangements in the receptor. As this opposition leads to conformational changes in the 
transducer itself, it constitutes a signal transfer (in detail in [113]). 
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Figure 3.10 Structures of NpSRII active site. a) Structural differences between NpSRII ground state in 
I212121 space group (yellow) and in P21212 space group (green) and b) between NpSRII M state in I212121 
space group (yellow) and in P21212 space group (green). 
 
Figure 3.11 Structural differences between NpSRII ground state (yellow) and the M state intermediate 
(magenta) in the vicinity of the retinal Schiff base including water molecules, Lys205, Asp75, Asp201, 
Arg72, Thr79, Trp76, Trp171. Water molecules are depicted as spheres. 
The structure of the M state is based on difference Fo-Fo Fourier maps, where the structure factor 
amplitudes are taken as difference between the amplitudes from the illuminated crystal and the ground 
state crystal, and the phases are calculated from the ground state structure. These maps reveal the rotation 
of Asp75 residue, displacement of water molecules and retinal isomerization. 
 
 
 68 
 
 
Figure 3.12 Overall structural rearrangements in NpSRII upon transition to the active state. (a) Structural 
rearrangements in uncomplexed NpSRII. (b) Structural rearrangements in NpSRII in complex with 
NpHtrII9 (Protein Data Bank ID: 2F95). The ground state is shown in blue, and the active state is shown in 
magenta. NpHtrII in (b) is shown in gray for both states. Lysine 205, retinal and tyrosine 199 are shown as 
ball-and-stick models. NpSRII helices are marked by corresponding letters (larger letters correspond to front 
helices and smaller letters correspond to back helices). Arrows show the movements of the corresponding 
helices. Alignment was performed by NpSRII backbone atoms. From [113]. 
 
Figure 3.13 The double distance matrix plot showing differences between the ground state structure of the 
wild type complex and the M state structure in I212121 space group. Chain A corresponds to SRII, chain B 
corresponds to HtrII. 
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The movement of the helix G of NpSRII initiates the movement of TM2 in NpHtrII. 
All hydrogen bonds between the receptor and the transducer observed for the ground state are 
still intact in the M state. A piston like movement of the cytoplasmic end of TM2 of about 0.5 
Å and rotation of 19° (15° in P21212) are observed and accompanied by alteration in the 
direction of Tyr199-Asn74 hydrogen bond. 
The similarity of the differences between the ground and the M states in the new type 
of crystals shows an overall robustness of the signal transduction mechanism in the membrane 
part of the complex.  
3.4. “U” and “V” shapes of the complex. Biological relevance 
Having established that the fine structure of the complex in the two crystal forms is 
unperturbed, we analyzed the overall structures in the crystal lattices. It is evident from Figure 
3.14 that the two receptors are oriented nearly parallel to the transducer and form a “U”-
shaped structure in the new crystal form I212121 comparing to the “V”-shaped structure with a 
crevice opened towards cytoplasmic side in the original P21212 symmetry. The corresponding 
angles with helix G as base are 15° and 40°, respectively. These large differences might 
account for the altered HAMP domain-NpSRII binding interfaces. Probably due to crystal 
lattice interactions, electron density in this region is not available for both cases. However, the 
molecular dynamic calculation revealed interesting insights. Taking the known structures of 
HAMP domains [16,18,120] (PDB codes 1ASW and 3LNR) as base computer modeling 
indicates that only the “U”-shape structure facilitates an interaction of between NpSRII and 
the HAMP domain. The results show that the HAMP domain is turned by about 90º around 
the 2-fold axis of the dimer normal to the membrane with respect to the homology model 
(Figure 4). On the other hand, molecular dynamics calculations using “V”-shaped topology 
showed a hollow in between the HAMP domain and NpSRII, which leads to weaker 
interactions between these proteins. 
“U” and “V” shaped conformations of SRII can be aligned by using the following 
orthogonal matrix (given by Coot): 
|    0.9943,    0.1061, -0.003439| 
|   -0.1059,    0.9892,   -0.1015| 
| -0.007367,    0.1013,    0.9948| 
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The cosine of the angle is then given by (a1+b2+c3-1)/2 = (0.9943+0.9892+0.9948-
1)/2 = 0,98915. This gives us an angle of 8.5°.  
The surface of NpSRII reveals a unique group of charged and polar residues at the 
cytoplasmic ends of helix F (Lys-157, Ser-158, Arg-162, Arg-164 and Asn-165) and G (Asp-
214) (Figure 4.7.2). For Ser-154 to Lys-157 an interaction with the transducer has been 
proven by ssNMR experiments [45]. From our model this patch of amino acids could interact 
with Asp85, Ser91, Asp115, Glu116 and Asp119 on TM2 via electrostatic interactions. 
Furthermore, Lys21 of TM1 and Asp214 of the helix G could form a salt bridge and might 
contribute to the overall stability of the complex conveyed by the HAMP domain-receptor 
interaction. It should be noted that these results on the “U”-shape of the complex explain well 
the spectroscopic data that shows that the EF loop interacts with the transducer [41,42,45]. 
Further evidence for the tight binding interface between the transducer and the 
receptor stems from calorimetric studies [43], solution NMR studies [44] and EPR 
experiments [14]. Thus, there is an ample experimental evidence for the tight interaction 
between SRII and the linker domain which is only possible in the “U”-shape assembly of the 
complex. 
 
Figure 3.14 “V”- and “U”-shapes of the wild type dimer as seen along the membrane. Helices G are shown as 
cylinders. The angle is shown between two helices G belonging to different receptor molecules within a dimer. 
The structure solved in the I212121 space group (“U”-shape, PDB ID 4GY6) is shown in yellow, the structure 
solved in the P21212 space group (“V”-shape, PDB ID 1H2S) is shown in green. Primes denote symmetry 
mates. 
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Figure 3.15 Electrostatic interactions between the receptor molecule and the HAMP domain. Interacting 
patches in the receptor and the transducer are shown and the G-D-G-D-L-D patch of the transducer proposed 
previously in literature as interacting with SRII. Positive charges are mapped in blue and negative are 
mapped in red. The expected salt bridges are: Asp214 (NpSRII) to Lys21 (NpHtrII), Lys157 (NpSRII) to 
Asp119 and Glu116 (NpHtrII). 
Further evidence for the tight binding interface between the transducer and the 
receptor stems from calorimetric studies [43], solution NMR studies [44] and EPR 
experiments [14]. Thus, there is an ample experimental evidence for the tight interaction 
between SRII and the linker domain which is only possible in the “U”-shape assembly of the 
complex. 
In contrast to the ground, in the M state the interaction between SRII and HtrII is 
considerably weakened (dissociation constants are 0.10 μM and 15 μM correspondingly)  
[121,122]. This effect can originate from a perturbation of the linker region but not from the 
membrane part of the proteins since interactions (especially, the hydrogen bonds interactions) 
are nearly the same in the both states. It is interesting that the HAMP domain itself 
(NpHtrII
G83-Q149
) interacts with the receptor in the ground, but not in the M state. Since the 
“U”-shape provides quite constrained room for conformational changes of the HAMP 
domain; it may be that a transition from “U” to “V”-shape is involved in the signal 
propagation.  
In accordance with the computer studies, the HAMP domain region itself corresponds 
to an asymmetric conformation [16]. It may happen that the “U”- and “V”–shaped complexes 
just correspond to symmetric (“U”-shape) and asymmetric (“V”–shaped) states of the HAMP 
domains and, therefore, correspond to different functional states (the ground and the active 
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ones). We suggest that the “U”-shape corresponds to a symmetric state where the HAMP 
domain is stabilized in the rotated confirmation via the aforementioned electrostatic 
interactions with the receptor. The HAMP domain turns by about 90º around the 2-fold axes 
which is made possible by a high flexibility of the linker between the TM2, especially to the 
presence of Gly83-Gly84 of the amino acid repeat. This hypothesis is supported by one more 
well established fact: the G83F mutation completely inhibits signal transduction [70]. Indeed, 
replacing a small glycine by a considerably larger phenylalanine would limit the ability of the 
HAMP domain to rotate relative to the membrane part of the transducer and therefore the 
ground state is forbidden. In line with this reasoning are the data on the crystal structure of the 
NpSRII/NpHtrII1-135-G83F. Although, the crystallization conditions were the same as for the 
wild type “U”-shaped complex in the P64 space group, in this case the space group was 
P21212 giving the “V”-shape structure similar to those observed before [7].  
Further evidence in favor of functional significance of the “U”-shaped membrane 
protein NpSRII/NpHtrII complex was published recently [123]. The authors studied how 
photoexcitation of SRII affects the structures of the complex. They conducted two series of 90 
nsec molecular dynamics simulations of the complex linked with a modeled HAMP domain in 
the lipid bilayer using published “V”-shaped structures of the ground and the M intermediate 
states [6,7] as starting models. The most significant finding was that the orientations of the 
two SRII molecules changed in going from the ground state to the M state: Their ‘closed’ 
ground state can be correlated to our “U”-shaped topology, whereas their more flexible M 
state might represent the “V”-shape introduced in this paper.  
If we try to compare the energy of a photon with that necessary for ”U”-to-“V” 
transition, we will see that is sufficient to trigger such changes. The estimation is based on the 
paper by C. Nielsen et al [124]. The Table 5 of this paper indicates the free energy of the 
hydrophobic mismatch for a protein with a radius of 15 Å. According to this table, the 3.4 Å 
mismatch corresponds to the free energy of 15 kT. Taking into account the size of SRII and 
the change in the tilt angle of 10° we assume that in our case the membrane mismatch is about 
1 Å. Therefore, in our case ∆G= 15kT x (1/3.4)2 x 2 (for two proteins in one complex) = 2.6 
kT. Worth noting that in reality ∆G will be smaller as we deal with a tilt movement and not a 
uniform spring-like deformation. The energy of the photon is about 100 kT but about 80% is 
thermally dissipated in protein. Nevertheless, the rest 20 kT of energy is sufficient to trigger 
such conformational changes. 
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Summarizing, the “U”- and “V”-shaped structures of the NpSRII/NpHtrII complex 
may be crucial for the mechanism of signal propagation spanning the membrane domain and 
feeding into the HAMP domain. This work represents the first evidence that different space 
groups might freeze different functional states of proteins. It is therefore of a great importance 
not only to analyze distinct structural differences but also to take the overall crystal packing 
and quaternary structures into account. 
3.5. Structure of the signal transferring triple mutant of 
bacteriorhodopsin in complex with HtrII 
Bacteriorhodopsin is a proton pump from archaea, highly homologous to SRII [125]. 
Its main function is production of charge gradient by means of proton translocation across the 
membrane. This gradient is in turn used by ATP synthases for ATP production. 
Bacteriorhodopsin’s structure and mechanism of functioning are well studied [125–127] and 
the best X-ray structures have resolution of 1.4 Å [126].  
Despite of the high structural similarity between archaeal retinal proteins (SRI, SRII, 
BR. HR), their functions are totally different. Recently it was shown that three residues in BR 
replaced by the corresponding residues in SRII allow BR to effectively deliver the retinal 
photoisomerization signal to the SRII integral membrane transducer (HtrII) and induce robust 
phototaxis responses. A single replacement (Ala-215–Thr), bridging the retinal and the 
membrane-embedded surface, confers weak phototaxis signaling activity, and the additional 
two (surface substitutions Pro-200–Thr and Val-210–Tyr), expected to align 
bacteriorhodopsin and HtrII in similar juxtaposition as SRII and HtrII, greatly enhance the 
signaling [128]. 
In order to give structural insights on the mechanism of signal transduction from this 
triple mutant of BR (BR-3M) to HtrII the mutant construct of BR was created; the protein was 
expressed, purified, reconstituted into polar lipids together with HtrII and crystallized in 
mesophases. Detergent OG was used to change the parameters of mesophase with MO like a 
host lipid. MO/protein ratio (3:2) remained constant for all experiments, protein 
concentrations (as calculated for the BR-3M/HtrII) was varied as 25 and 35 mg/ml. Detergent 
concentration was varied from 1 to 5 % per MO (w/v). It should be mentioned that the 
complex of BR triple mutant and NpHtrII can only bear not very high detergent 
concentrations. Thus, for crystallizations with higher OG per MO concentrations (w/v) 
hexagonal crystals were formed but, as followed X-ray analysis demonstrated, they were not 
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the crystals of the complex but single BR. It can be explained as BR-3M/NpHtrII complex 
was dissociated by high amounts of OG [129]. 
 
Figure 3.16 Rhombic crystals of proteins complex BR-3M/NpHtrII grown from mesophases with addition of 
OG. First crystals appeared after 1 month and diffracted to 3 Å. Crystals belong to space group P21212 with 
unit cells parameters: a = 54.9, b = 88.6, c = 130.1 Å, α = 90º,  = 90º, γ = 90º. 
Rhombic crystals of proteins complex were obtained by nanovolume crystallization 
from mesophases with OG and MO (w/v) in the presence of high concentration ammonium 
phosphate as a precipitant (2.4 – 2.8 M). For mesophase contained less amount of detergent 
crystals were grown to the size 20 – 30 µm, whereas for higher OG percentages per MO (w/v) 
crystals reached 100 µm in diagonal (Figure 3.16). The significant improvement of crystals 
size and quality in answer to increase the detergent concentration is understandable in terms 
of paradigm of crystallization from mesophases [129]. 
First crystals appeared after 1 month and diffracted to 3 Å. Crystals belong to space 
group P21212 with unit cells parameters: a = 54.9, b = 88.6, c = 130.1 Å, α = 90º,  = 90º, γ = 
90º. The asymmetric unit contains 2 complexes of BR-3M and HtrII. 
BR and HtrII models were used for initial phase determination by molecular 
replacement. Only the membrane inserted part of the complex could be resolved in the 
electron density. The similar situation is observed in the case of SRII/HtrII complex. The 
electron densities after Leu82 of HtrII are very poor and the HAMP domain still couldn’t be 
built. 
A very interesting result was obtained while looking at the respective orientation of 
BR-3M and HtrII (Figure 3.17). As one can see, one transducer molecule forms a complex 
with BR-3M along the surface of F and G helices as it was expected from SRII/HtrII complex 
structure. Meanwhile, another HtrII molecule forms a complex with BR-3M along the surface 
of E and F helices that is much unexpected.  This finding is the first evidence of two possible 
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binding schemes between BR and HtrII. Obviously, the preference for F-G helix surface is 
much stronger in case of SRII. 
 
 
Figure 3.17 Structure of the BR-3M/HtrII complex. Left: view along the membrane plane; right: view 
perpendicular to the membrane plane. BR-3M is shown in purple, HtrII is shown in green. 
3.6. Expression, purification and crystallization of truncated 
parts of HtrII 
The geometrical parameters of SRII/HtrII complex do not allow crystallization of the 
complex in its native form. The transducer protein length in the direction perpendicular to the 
membrane is about 200 Å that is far beyond cubic phase possible lattice constants. Therefore, 
for crystallization purposes the HtrII construct was split into the membrane and water-soluble 
parts. Then, the membrane part was reconstituted into polar lipids together with SRII and 
crystallized using mesophases. Cytoplasmic part, which contains 2 HAMP domains, 
adaptation domain and kinase domain, was split into several parts taking into account 
predictions for domain boundaries and set up for crystallization separately, using approaches 
for water-soluble proteins. In this chapter constructs containing cytoplasmic parts of HtrII will 
be discussed. 
The following constructs were created using different expression vectors: HtrII-1-135, 
HtrII-83-210, HtrII-83-157, HtrII-83-135 and HtrII-83-534. The first construct contains 
transmembrane part and the first HAMP domain. It was crystallized in meso in complex with 
SRII (see above). Four other constructs comprise water-soluble parts of HtrII: “HAMP1” + 
“inter-HAMP linker” + “HAMP2”, “HAMP1” + “inter-HAMP linker”, “HAMP1”,  
“HAMP1” + “inter-HAMP linker” + “HAMP2” + “methylation domain” + “kinase domain” 
respectively (Figure 3.18). 
90° 
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HtrII-83-534 gene was synthesized by MWG Company. Other constructs were derived 
from this DNA matrix by PCR. HtrII-83-135 and HtrII-83-157 were inserted into pTYB12 
vector. The vector was transformed into BL21 Star expression strain. The expression was 
performed in auto-induction medium overnight at 37° C. The cells were harvested by 
centrifugation at 4500 RPM, 4° C for 30 min. Cell pellets were dissolved in cell buffer (see 
Methods and Materials section) and disrupted in a microfluidizer. After breaking, the cell 
debris were centrifugated again at 35 000 RPM, 4° C for 1 h, and the pellet was discarded. 
Soluble fractions were loaded on chitin beads column and the binding was performed 
overnight at RT. Intein cleavage and subsequent elution were induced by adding the buffer 
containing 40 mM DTT. Elution fractions contained considerable amount of precursor protein 
(target protein + intein) and intein itself (Figure 3.19). In order to get pure target protein either 
of the two strategies was applied: 1) size-exclusion chromatography 2) additional run through 
the chitin beads, were additives containing intein were bound to the resin. First method gave 
better result though it is more time consuming. The letter is straightforward and high-
throughput but occasionally leads to the loss of considerable amounts of protein. 
 
Figure 3.18 For crystallization purposes HtrII 
was split into several parts. Membrane part 
(containing residues 1-135 or 1-157) was 
crystallized in complex with SRII and has yielded 
crystals diffracting up to 1.7 Å. Cytoplasmic 
water-soluble part of HtrII was truncated 
between domain boundaries and different 
domains were expressed separately. The 
following constructs were made: 
1. HtrII-1-135 (membrane + HAMP1) 
2. HtrII-83-210 (HAMP1 + inter-HAMP-linker + 
HAMP2) 
3. HtrII-83-157 (HAMP1 + inter-HAMP-linker) 
4. HtrII-83-135 (HAMP1) 
5. HtrII-83-534 (HAMP1 + inter-HAMP linker + 
HAMP2 + methylation domain + kinase domain) 
Unfortunately, stability tests have shown that the both constructs containing only 
HAMP1 are not stable enough to be used for crystallization.  The protein degrades quickly 
during storage at 4° C and after several freeze/thaw cycles. Nevertheless, some preliminary 
crystallization screening was performed but no crystals were obtained. 
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Figure 3.19 Expression of HtrII-83-135 in auto-
induction medium. 
1,3. Crude lysates in BL21 (DE3) and Lemo21 cells 
2,4. Solubilized membrane fraction 
5,6,7. Elution fractions 
HtrII-83-210 and HtrII-83-534 were inserted into vector pStaby1.2. This vector was 
chosen as it has a specific plasmid stabilization system. In the StabyExpress system, the 
antidote gene (ccdA) is inserted into the plasmid DNA under the control of a constitutive 
promoter. On the other hand, the toxic gene (ccdB) is inserted in the chromosome of the SE1 
bacterial strain. Expression of the poison gene is under the control of a promoter strongly 
repressed in the presence of the plasmid. When the plasmid is lost, the antidote is degraded 
and the production of the toxin is induced, causing cell death. Practically, this means that 
when during the pre-induction phase bacteria are grown, 100% of the bacteria will carry the 
vector. If they lose the vector, they will not obtain a growth advantage, but will die.  Upon 
induction 100% of the bacteria will start producing the recombinant protein leading to higher 
yields of the target protein and less background caused by unwanted proteins (for details see 
StabyExpress Manual, Eurogenetec). 
 
Figure 3.20 Purification of HtrII-83-534 under denaturing 
conditions.  
1.Control in native conditions (300mM NaCl, 20 mM Tris 
pH8.3) 
2. Control + 6M urea 
3.Control + 6M GuHCl 
4. Control + 6M GuHCl + 0.1% Tween20 
5.Protein solution before purification 
 
HtrII-83-210 and HtrII-83-534 were expressed in auto-induction medium ZYP-5052. 
In order to avoid formation of inclusion bodies and ensure proper protein folding, the cells 
were grown at 37° C until all glucose was consumed and induction by lactose was started. 
Typically, that corresponds to OD=2 and 3 hours of broth incubation. The cells were 
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harvested and disrupted in the same manner as for other constructs (see above). Target 
proteins were bound to Ni-NTA resin after incubation for 2 hours in the cold room. 
Subsequent washing of the resin and elution by 200 mM Imidazole solution were performed 
using ÄKTA Prime purification system. 
 
Figure 3.21 Purification of HtrII-83-210 and HtrII-1-
135 
1. Crude lysate HtrII-83-210 
2.Protein HtrII-83-210 resolubilized after precipitation 
in ammonium sulfate 
3.Insoluble pellet of HtrII-83-210 after precipitation in 
ammonium sulfate 
4-5. HtrII-1-135 after purification of chitin beads. 
While in case of HtrII-83-210 purification resulted into pure protein suitable for 
crystallization (Figure 3.21 represents PAGE gel of Ni-NTA purification), HtrII-83-534 
couldn’t be produced in unambiguously pure form. Elution fractions from Ni-NTA column 
contained major band corresponding to the protein of interest and a lot of impurities of 
different molecular weight. Additional analysis was performed in order to purify the protein 
under denaturing conditions (see Figure 3.20). As we can see, denaturing conditions indeed 
lead to more pure protein. 
 
Figure 3.22 Plasmid map bearing HtrII-83-210. The construct was inserted into pStaby1.2 vector by NdeI and 
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XhoI restriction sites. 
Additional purification of HtrII-83-534 was done using size-exclusion 
chromatography using Superose 6pg matrix on the column XK 16/100. The gel filtration was 
performed at 4°C. The major elution peak is positioned at 139.9 ml corresponds to Kd of the 
protein of interest. Unfortunately, PAGE analysis has shown that there was no good 
separation between target protein and other proteins in solution (Figure 3.23). Obviously, the 
protein runs as a complex together with side products or products of its own degradation. In 
overall, this construct turned out to be not suitable for crystallization experiments. 
 
Figure 3.23 PAGE gel of SEC elution of 
HtrII-83-524 construct 
Lanes 1-9 show serial elution fractions 
For crystallization screening HtrII-83-210 was concentrated in a centrifugal membrane 
concentrator (MWCO 10 KDa) to the concentration of 15 mg/ml and submitted for 
crystallization to HTXLab in EMBL Grenoble. The crystallization was done as a sitting drop. 
Each trial contained 50 nl of protein solution mixed with 800 µl of mother solution. 
Crystallization was set up at 20°C. The following kits were used: Crystal Screen Lite & 
PEG/Ion; QuickScreen & Grid screens Ammonium Sulfate, Sodium Malonate - Sodium 
Formate; Grid screens PEG 6K, PEG/LiCl, MPD - Screen Mme (all from Hampton) and The 
Classics (from Qiagen). Unfortunately, neither of crystallization conditions yielded any 
crystals. A lot of trials contained precipitate that is an indication of poor protein stability. 
The molecular constructs of the cytoplasmic parts HtrII could be expressed in high 
yield. Nevertheless, they turned out to be difficult to purify and to keep in a stable water-
soluble state. Apparently, the conditions of the standard molecular biology buffers differ a lot 
from the environmental conditions of the cytoplasm in halobacteria. The amino acid 
composition of HtrII might have evolved to adapt to these conditions. This fact leads to the 
aforementioned problems. In turn, buffers with high ionic strength are not comparable with 
most methods of protein purification. Nevertheless, as the buffer conditions of the 
crystallization trial tend to the high molarity of the precipitant salt in course of crystallization, 
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at some point these conditions might become suitable for proper folding of the protein. These 
crystallization experiments are ongoing. 
 
Figure 3.24 Elution profile of HtrII-83-534 construct purified using size-exclusion chromatography on 
column Superose 6PG, total volume 180 ml. 
3.7. The structure of SRII in complex with HtrII-135 and G83F 
mutation of HtrII-135 
Since the SRII/HtrII-157 construct didn’t result into any reasonable electron densities 
in the HAMP domain area, it was decided to make molecular constructs of HtrII that could 
tackle with possible problems that led to the HAMP domain instability in crystals. One of 
these reasons could be the fact that HtrII-157 doesn’t fit into water channel on the cubic 
phase. If we try to model the HAMP domain into the obtained structure of the complex we see 
that it only fits when being truncated after amino acid 135 (Figure 3.25). Therefore, any 
additional amino acids after position 135 would be unsuitable for proper HAMP domain 
folding. Moreover, only the space group I212121 has cavity in this area big enough to 
accommodate the domain (Figure 3.26). In this sense P21212 is much less favorable as in this 
space group HtrII molecules in a crystal are placed one under another in the neighboring 
layers thereby excluding space for the HAMP domain. 
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Figure 3.25 Space for the HAMP domain in I212121 crystal lattice. The αββα homodimer of SRII/HtrII 
membrane part is shown as green and marine surface, HAMP dimer is shown as white surface and the 
complex in the next crystal layer is shown as red and blue mesh. The HAMP domain has some steric clashes 
 
Figure 3.26 a) “V”-shaped NpSRII/NpHtrII complex in P21212 space group. b) “U”-shaped NpSRII/NpHtrII 
complex in I212121 space group. Figures on the left show two subsequent crystal layers as seen along the 
membrane plane. Figures on the right show a single crystal layer as seen perpendicular to the membrane 
plane. NpSRII molecules are shown in green; parts of NpHtrII molecules resolved in the crystal structure are 
shown in blue. Models of NpHtrII that continue to the HAMP domain are shown in red. Residues 83-136 in 
these models are modeled by homology with NMR structure 2ASW. In a) a big steric clash can be seen 
between the model of the HAMP domain from one crystal layer and the corresponding NpHtrII molecule 
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from the other crystal layer. There are no observed steric clashes between the model of the HAMP domain 
from one layer and NpSRII/NpHtrII molecules from the other layer in b) (Figure provided by S. Grudinin). 
 
The pTXB1 plasmid with HtrII-1-135 gene was kindly provided by Prof. Engelhard 
(MPI Dortmund). Expression was performed according to the standard protocol of IMPACT 
kit (see Methods and Materials section). The protein was eluted by addition of 200 mM 
Mesna to the elution buffer and incubation for 1 day at room temperature. It was determined 
that elution at lower temperature or shorter incubation times is ineffective, and a lot of protein 
remains bound to the chitin beads. Mesna was removed by dialysis against 300 mM NaCl, 20 
mM Tris and 0.1% DDM pH8 buffer. PAGE analysis showed that elution fractions may 
contain a lot of target protein bound to Intein or Intein alone (Figure 3.27). For additional 
purification of the target protein it was applied to the chitin column one more time. In this 
case Intein-containing impurities were bound to the resin while the target protein could be 
collected in the flow through. As a final step of purification, the reconstitution into polar 
lipids and buffer exchange has helped to remove any water soluble contaminants. 
For crystallization the SRII/HtrII complex was reconstituted into the polar lipids of 
purple membranes. To do that, equal amounts of protein and lipids (wt/wt) were mixed with 
biobeads (approx. 30% of volume) and left on shaker overnight. After reconstitution the 
protein was concentrated by centrifugation to 30 mg/ml and mixed with equal amount of MO. 
The cubic phase was formed after 1 day and then dispensed using Formulatrix NT8 robot and 
kits from Hampton and Qiagen. First crystals appeared after 2-3 weeks and continued to grow 
for 3-4 months. The largest crystals exceeded 200 Å in size and diffracted to 2 Å. 
 
Figure 3.27 Expression of HtrII-135 
Lane1: Chitin beads after elution 
Lane 2: Eluted protein 
Lane3: Flow through 
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The structure was solved in P64 space group. In this space group twinning is possible 
but it was detected to be on negligible level (about 5%). All the features of previously solved 
structures remained the same including the structure of the active site and the “U”-shape. 
 
  
  
  
Figure 3.28 Different crystal forms of SRII/HtrII-135 complex. Hexagonal, rhombic and needle-like crystals 
were observed. The best crystals were obtained in the conditions were ammonium sulfate was used as a 
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precipitant. The pH range varies from 5 to 8.5. Typically, hexagonal crystals were of the best quality 
comparing to other types. The resolution of the datasets from plate-like and rhombic crystals was marginal.   
 
Figure 3.29 Electron density in the HAMP domain area in the crystals of SRII/HtrII-135 complex in P64 
space group contoured at σ=1.0. The structure of TM2 ends with Gly84.  
Unfortunately, the new crystal form also didn’t provide any information about the 
structure of the HAMP domain. Since further truncation of HtrII was not possible without 
disturbing native HAMP1 domain structure that ends at amino acid residue number 135, other 
strategies had to be implemented.  
As it was mentioned before, two glycines in HtrII just before the HAMP domain 
sequence may result into domain’s flexibility. Moreover, it is known that G83F mutation 
impairs signal transduction.  
 
Figure 3.30 Expression of HtrII-135-G83F 
1. Elution fraction of HtrII-135-G83F after addition of 40 mM DTT 
2. Flow through 
The G83F mutant of HtrII-135 molecular construct was designed, the mutation was 
introduced using conventional PCR method. Crystallization was performed using the same 
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procedure as for wild type complex. The optimal concentration of the protein was chosen to 
be 20-30 mg/ml as for the wild type HtrII. Two types of crystals were observed: hexagonal 
and needle-like crystals. Crystal growth took 1-2 months. Hexagonal crystals of the complex 
NpSRII/NpHtrII-G83F appeared at the similar conditions as the crystals of wild type complex 
– precipitant 1.4 M Ammonium sulfate, pH 5.2-8.2. Needle-like crystals were obtained in 
crystallization probes with 2.2-2.8 M Ammonium phosphate as a precipitant, pH 7.0-7.6. 
Crystals were harvested from LCP-sandwich and used for X-ray data collection. The crystals 
of NpSRII/NpHtrII-G83F from nanovolume crystallization from mesophases diffracted to 
2.7-3.0 Å resolution. 
Though, crystals appeared in the same crystallization conditions, they belonged to 
P212121 space group and contained two molecules in the asymmetric unit. Surprisingly, in this 
case the quaternary structure appeared as “V”-shape. This is an indication of importance of 
the mutation for the structure of the complex. Nevertheless, the electron densities still didn’t 
allow building the structure of the HAMP domain. 
 
Figure 3.31 Electron densities in the C-
terminus of HtrII. Gly83 was mutated to 
Phe83. 
The “V”-shape structure of the complex may represent some of the intermediate states 
(see Chapter 3.4). Taking this into account the new finding makes sense. It is known that 
G83F somehow disturbs the signal transduction mechanism in the SRII/HtrII complex. The 
reason for that could be that the proteins get fixed in a constitutive signaling state and, 
consequently, get crystallized in that state thereby forming the “V”-shape quaternary 
structure.   
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3.8. Expression, purification, characterization and 
crystallization of chemoreceptors NarQ and NarX 
In order to get an insight on the initial steps of signal transduction in chemoreceptors, 
the membrane domains of nitrate/nitrite sensing proteins NarQ and NarX were expressed, 
purified and crystallized. As in meso crystallization method implies restrictions in the size of 
the protein perpendicular to the membrane and in order to reduce possible thermal 
fluctuations, the molecular construct that was expressed contained only amino acid range 1-
231 in case of NarQ and 1-225 in case of NarX. These ranges comprise the extracellular 
sensory part, transmembrane domains and the intracellular HAMP domains. The genes were 
taken by PCR from a single colony of E.coli BL21 strain using following pairs of primers: 
AGACATTGCTGACTGTTGGCCATAATAAAA and 
GGTGCCACTGCTCTGAGATGACATATAC (NarQ); 
GATAAGCTGTTTTACGCCAGTTCGCAGCATC and 
GTATACTTCAGCCAATAGCCGAGAATACTGCCATT (NarX). After genes were 
extracted from the genome, they were cloned into pStaby1.2 expression vector. To do that an 
addition PCR was performed that introduced NdeI and XhoI restriction sites. Plasmid with the 
gene was transformed into SE1 strain that was used for expression. 
 
Figure 3.32 Plasmid map of the construct NarQ-1-231. The gene fragment was inserted by NdeI and XhoI 
restriction sites. Plasmid possesses anti-ampicillin resistance gene and special plasmid stabilization gene 
(ccdA). 
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Figure 3.33 Plasmid map of the construct NarX-1-225. The gene fragment was inserted by NdeI and XhoI 
restriction sites. Plasmid possesses anti-ampicillin resistance gene and special plasmid stabilization gene 
(ccdA). 
NarQ and NarX proteins were expressed using auto-induction medium developed by 
William Studier and colleagues [130]. Among all available auto-induction medium protocols 
the ZYP-5052 medium was chosen. The medium composition is as follows: 
ZY: 1% tryptone, 0.5% yeast extract, autoclaved 
20xNPS: 1M Na2HPO4, 1M K2HPO4, 500 mM (NH4)2SO4, autoclaved 
50 x 5052: 25% glycerol, 2.5% glucose, 10% alpha-lactose monohydrate, sterile 
filtered 
1000X trace metals: 50mM FeCl3, 20mM CaCl2, 10mM MnCl2, 10mM ZnSO4, 2mM 
CoCl2, 2mM CuCl2, 2mM NiCl2, 2mM Na2MoO4, 2mM H3BO3, Made in 60mM HCl, 
autoclaved 
MgSO4 2 mM, autoclaved 
In order to get ZYP-5052 928 ml ZY was added to 50 ml 20xNPS, 20 ml 50x5052, 
2ml MgSO4 and 0.2 ml 1000X trace elements with appropriate antibiotic.  
Precultures were grown overnight in LB or 2xYT medium and diluted 20-30 fold to 
obtain starting main culture. The broth was incubated in shaker at 37° C for two hours and 
after that the temperature was decreased to 30° C and incubated so overnight. The cells were 
harvested in the morning by spinning down in the centrifuge at 5000 rpm. The yield was 2-3 
mg from a 1 l of cell culture. Then, the cells were either frozen in liquid nitrogen for storage 
or disrupted in a microfluidizer after dilution in PBS buffer with addition of one tablet of 
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EDTA-free protease inhibitor cocktail Complete (Roche). After disruption cellular 
membranes were collected by centrifugation at 35 000 rpm.  
The protein was extracted from the membrane by overnight solubilization in 300 mM 
NaCl, 50 mM NaPi and 2% DDM pH8.0. Then, the protein was applied to Ni-NTA column; 
binding was achieved in 1-3 hours. The resin was extensively washed with the washing buffer 
(300mM NaCl, 20 mM Tris, 0.1% DDM pH 8.0). The elution was done in elution buffer 
(300mM NaCl, 20 mM Tris, 200 mM Imidazole, 0.1% DDM pH8.0). Imidazole was removed 
by dialysis against 300mM NaCl, 20 mM Tris, 200 mM Imidazole and 0.1% DDM pH8.0. 
  
Figure 3.34 PAGE analysis of the purification 
process of the construct NarX-1-225 
1. Cytoplasmic fraction 
2. Membrane before fraction before solubilization 
3. Membrane fraction after solubilization 
4. Supernatant after solubilization 
5. Ni-NTA column flow-through 
6-11. Elution fractions from Ni-NTA column. 
 
Figure 3.35 WB analysis of the purification process 
of the construct NarX-1-225 
1. Cytoplasmic fraction 
2. Membrane before fraction before solubilization 
3. Membrane fraction after solubilization 
4. Supernatant after solubilization 
5. Ni-NTA column flow-through 
6-11. Elution fractions from Ni-NTA column. 
White pellet was observed in elution fractions from Ni-NTA purification and after 
dialysis. Though this pellet contains target protein, the major mass of the protein was still in 
the solution. The same pellet was observed in test purification using OG as solubilizing 
detergent (not discussed here). The conclusion is that the protein might not be sufficiently 
stable in these detergents and additional detergent screening would be necessary. The pellet 
was not observed when relatively harsh detergents were used (NLS, SDS).    
The identity of the protein was verified by MALDI-TOF mass spectrometry (for 
detailed sample preparation description see Methods section). In brief, two methods were 
used: in-gel digestion and extraction and intact protein analysis. The following figure presents 
the MALDI-TOF spectrum of intact NarQ-1-231 solubilized in 2% DDM. 
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Sample 
observed mass 
(Da) 
expected mass 
(Da) 
mass deviation 
(Da) 
mass 
accuracy 
(ppm)* 
interpretation 
NarQ-1-231 
26751.5 
20507.2 
13353.0 
10216.2 
26779.97 
 
 
 
28.5 
 
 
 
1064 
 
 
 
In agreement 
Truncated form of the protein (?) 
Double charged ion of 26751.5 
Double charged ion of 20507.2 
 
For initial crystallization screening NarQ-1-231 was concentrated in a centrifugal 
membrane concentrator (MWCO 30 KDa) to the concentration of 15 mg/ml and submitted for 
crystallization to HTXLab in EMBL Grenoble. Crystallization was set up at 20°C. The 
following kits were used: Crystal Screen Lite & PEG/Ion; MembFac & Natrix; QuickScreen 
& Grid screens Ammonium Sulfate, Sodium Malonate - Sodium Formate; Grid screens PEG 
6K, PEG/LiCl, MPD - Screen Mme (all from Hampton) and The Classics (from Qiagen). First 
cubic crystals 20µm in size appeared in 50 days (Figure 3.36), belonging to space group I222 
(lattice constants 81 Å, 149 Å, 158 Å, 90°, 90°, 90°) in Qiagen-The Classics kit with 
conditions 0.1 M tri-sodium citrate, 20% isopropanol, 20% PEG4000 pH 5.6.  
The crystals were fished using standard protocol by Cherezov et al. [131] into 
MiTeGen cryoloops and flash frozen in liquid nitrogen without cryoprotectant. The 
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diffraction quality was tested at ESRF ID23-1 beamline and the Bragg peaks were tractable to 
the resolution up to 5 Å.  
  
Figure 3.36 A photo of NarQ-1-231 crystals 
obtained by in surfo crystallization method 
Figure 3.37 Diffraction pattern of NarQ-1-231 
crystal  
 
These experiments have confirmed that this construct is suitable for crystallization. 
Since the membrane proteins solubilized in DDM detergent usually don’t form well-
diffracting crystals, there is obviously still some room for quality improvement. The next 
setup was done for in meso crystallization.  The protein solution in buffer 300 mM NaCl, 20 
mM Tris pH 8, 2% DDM, was used to make crystallization setups. The protein/lipid mixture 
was mixed with lipid monooleoyl by 2:3 ratio using connected syringes. The meso-phase was 
formed after 1-2 days. After the phase formation, the protein/lipid/detergent mixture was 
dispensed using Formulatrix NT8 robot by 50 nl into each crystallization drop. Mother 
solution was dispensed by 800 nl into each drop. The following crystallization kits were used: 
Qiagen Cubic Phase I, Qiagen Cubic Phase II and Molecular Dimensions MemStart & 
MemSys. First crystals appeared after one month under various conditions in the kit Qiagen 
Cubic Phase II in probes containing 5% OG. 
 
Figure 3.38 A photo of NarQ-1-231 crystals 
obtained by in surfo crystallization method 
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Main results and perspectives overview 
 The structure of D75N mutant of SRII in a complex with HtrII was obtained with the 
resolution of 2 Å. The complex was crystallized using novel methods of nanovolume 
crystallization from mesophases using robotic technologies. The structure of the active 
site of SRII was analyzed. Possible mechanism of signal transfer in this complex is 
proposed. 
 Different structures of the SRII/HtrII complex (resolution range 1.7-3.0 Å) have 
revealed two possible quaternary structures, which differ in the relative angle of the 
homodimer. They were called “V”-shape (for the structure initially observed in P21212 
space group) and ”U”-shape (for the structure initially observed in I212121 space 
group). The relevance of this finding for understanding of the signal transduction 
mechanism in the complex is discussed. 
 Various molecular constructs aiming to elucidate the structure of the cytoplasmic part 
of HtrII (and, particularly, the HAMP domain) were produced, expressed and purified. 
Unfortunately, the crystallization trials didn’t succeed for the moment of thesis 
preparation. 
 Nitrate/nitrite receptors NarQ and NarX from E.coli were studied. Plasmid constructs 
containing membrane and cytoplasmic parts of the proteins were created. The proteins 
were expressed and purified. The first crystals diffracting to 5 Å were obtained. 
Crystallization optimization is ongoing at the moment. 
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Concluding remarks 
Interactions between SRII and HtrII are of broad interest with respect to the 
mechanism of signal transduction in archaea and its close relationship to the chemotaxis in 
eubacteria. This thesis presents a new crystal form, D75N mutant and intermediate trapping 
study of sensory rhodopsin II in a complex with its transducer protein (HtrlI), both of which 
are cloned from the host halobacteria N. pharaonis. The major new finding of this work is a 
new structure of the complex in the space group I212121 rather than P21212 from which all 
earlier studies have been reported. A third crystal form, in P64, is also reported for a shorter 
HtrII construct (truncated at residue 135). Two SRII molecules in the dimer are inclined at an 
angle of about 15 degrees relative to each other in I212121 whereas they are at an angle of 35 
degrees in the earlier P21212 crystal packing. This raises the question as: which crystal form 
most accurately models the packing of the SRII/HtrII complex in the native N. pharaonis 
membrane? 
 
A view on the SRII/HtrII complex along the membrane. The “U”-shape structure is shown in yellow and the 
“V”-shape structure is shown in green. The red line indicates an axis of rigid body rotation during 
transformation of SRII from “V”-shape to “U”-shape. 
 
Analysis of the homology model containing the HAMP domain indicates that the “U”-
shape structure is a much better “candidate” for the ground state structure than the “V” shape. 
Another support of this idea is the fact that independent molecular dynamics studies have 
shown that the “V”-shape structure can transform into “U”-shape structure. The role of the 
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“V”-shape is not obvious. Taking into account various studies of interaction between the 
HAMP domain and SRII, especially EF loop, one can see that the connection between them 
loosens upon transition of the complex into active state. This is exactly the case of the “V”-
shape where the HAMP domain is situated too far from SRII to form any hydrogen bonds or 
to have a strong electrostatic interaction. Therefore, it is suggested that “V”-shape might be an 
active form of the complex. If this is true then one should distinguish between 
spectroscopically distinct ground and M states on one side that are so far mostly characterized 
structurally by changes in the active site (first of all, isomerization state of the retinal), and 
“U” and “V”-shapes on the other side that appear in experiment under different crystallization 
conditions and cannot be interconverted in a single crystal. Ideally, if the theory is correct, in 
living systems the “U”-shape with all-trans retinal should represent the ground state and the 
“V”-shape with 13-cis retinal would represent the active state. The energy for such transition 
would then be converted from the energy of the incident photon, which is about 100 kT, while 
the energy of the mismatch between structures is estimated below 15 kT. 
The D75N mutant of NpSRII-NpHtrII has been shown to exhibit wild-type phototaxis 
signaling activity in vivo, with the mutant complex modulating the motility system in a 
manner indistinguishable from the wild-type complex both in the dark and in the 
light. Meanwhile, the homologous complex from H. salinarum is constitutively active. The 
complex of NpSRII-D75N/NpHtrII was crystallized to the resolution of 2 Å that is sufficient 
for analyzing the hydrogen bond network in the active core of SRII. It was shown that in 
terms of hydrogen bonds number this mutant complex is in between the ground state and the 
M state of the wild type. Since no movements of helices were detected, it was suggested the 
existing hydrogen bonds network is sufficient to maintain SRII-D75N structure in the ground 
state. 
Unfortunately, despite numerous efforts and embodied experiments, the structure of 
the HAMP domain couldn’t be solved. Structures of truncated HtrII in complex with SRII 
revealed only the membrane part of the proteins. Various constructs of water-soluble parts of 
HtrII also didn’t result in any crystals. The most probable reason is domain’s thermal 
instability and unfolding under low-salt conditions. 
NarQ and NarX proteins represent an important family of transmembrane histidine 
kinases. They contain one HAMP domain and in their structure in general are highly similar 
to HtrII. As the genes come from E.coli, investigation of their structure and mechanism of 
functioning is of high practical importance. Moreover, in these systems the HAMP domain 
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structure may be more robust and easier to obtain in a folded state. By now the first crystals 
diffracting to 5 Å were obtained. 
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Appendix I 
Table 1. Crystallographic data collection and refinement statistics for the wild type 
complex SRII/HtrII 
 Ground State, HtrII 
truncated at resid. 
157 
M State, HtrII 
truncated at resid. 
157 
Ground State, 
HtrII truncated at 
resid. 135 
Data collection    
Space group I212121 I212121 P64 
Cell dimensions      
    a, b, c (Å) 49.64, 113.66, 125.99 49.56, 113.78, 125.39 66.31, 66.31, 170.08 
    α, β, γ  (°)  90, 90, 90 90, 90, 90 90,90,120 
Resolution (Å) 28.0-1.9 (1.97-1.90*) 36.0-1.9 (1.97-1.90*) 34.0-2.5 (2.59-
2.50*) 
Rmerge (%)  7.0 (39.3*) 5.1 (14.4*) 9.0 (39.6*) 
I / σI 13.4 (2.4*) 18.7 (3.8*)  11.16 (2.1*) 
Completeness (%) 99.4 (99.8*) 98.6 (95.6*) 77.6 (73.4*) 
Redundancy 3.8 (3.5*) 3.4 (3.3*) 5.2 (5.5*) 
    
Refinement    
Resolution (Å) 22-1.9 36-1.9 34-2.5 
No. reflections 28430 (1423**) 28034 (1402**) 20997 (1080**) 
Rwork / Rfree (%) 19.66 / 21.83 20.15 / 23.24 19.32 / 23.37 
No. atoms    
    Protein 2090 4180 (2090***) 2034 
    Ligand/ion 171 191 (171***) 110 
    Water 56 110 (54***) 26 
B-factors    
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    Protein 22.70 24.30 (23.90***) 56.10 
    Ligand/ion 41.70 44.40 (48.50***) 69.70 
    Water 32.20 33.60 (32.90***) 59.70 
R.m.s. deviations    
    Bond lengths (Å) 0.011 0.010 0.012 
    Bond angles (°) 1.23 1.30 1.87 
 
*Values in parentheses are for high-resolution shell. 
** Number of reflection not used for refinement (free reflections) 
*** Number of atoms whose position was refined (atoms of active-state model) 
Rmerge=∑h∑i|I(h,i)-<I(h)>|/∑h∑i|I(h,i)|× 100 %, where I(h,i) is the intensity value of the ith 
measurement of h and <I(h)> is the corresponding mean value of h for all I measurements of h. The summation 
is over all measurements. 
Rwork = ∑⎪Fo-Fc⎪/⎪∑Fo⎪× 100 %. 
Rfree was calculated for 5% of observed reflections, omitted from the refinement and Rwork 
calculation and picked randomly within thin resolution shells.  
 
 
Table 2. Crystallographic data collection and refinement statistics for the complex 
SRII-D75N/HtrII 
 SRII-D75N/HtrII 
Data collection  
Space group I212121 
Cell dimensions    
    a, b, c (Å) 49.47, 113.67, 126.19 
    α, β, γ  (°)  90, 90, 90 
Resolution (Å) 42-2.05 (2.12-2.05)* 
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Rmerge (%)  6.1 (40.6) 
I / σI 15.0 (2.6)* 
Completeness (%) 99.86(100.00) 
Redundancy 3.7 (3.5)* 
  
Refinement  
Resolution (Å) 42-2.05 
No. reflections 22752 (1132**) 
Rwork / Rfree (%) 20.26/22.29 
No. atoms  
    Protein 2053 
    Ligand/ion 102 
    Water 70 
B-factors  
    Protein 25.10 
    Ligand/ion 38.30 
    Water 40.10 
R.m.s. deviations  
    Bond lengths (Å) 0.011 
    Bond angles (°) 1.13 
 
*Values in parentheses are for highest-resolution shell. 
** Number of reflection not used for refinement (free reflections) 
*** Number of atoms whose position was refined (atoms of active-state model) 
Rmerge=∑h∑i|I(h,i )- <I(h)>|/∑h∑i|I(h,i)| ×100 %, where I(h,i) is the intensity value of the ith 
measurement of h and <I(h)> is the corresponding mean value of h for all I measurements of h. The summation 
is over all measurements. 
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Rwork = ∑⎪Fo - Fc⎪/⎪∑Fo⎪× 100 %. 
Rfree was calculated for 5% of observed reflections, omitted from the refinement and Rwork 
calculation, picked randomly within thin resolution shells.  
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Appendix II 
Amino-acid sequences of protein constructs (together with expression tags) 
SRII: 
VGLTTLFWLGAIGMLVGTLAFAWAGRDAGSGERRYYVTLVGISGIAAVAYV
VMALGVGWVPVAERTVFAPRYIDWILTTPLIVYFLGLLAGLDSREFGIVITLNT
VVMLAGFAGAMVPGIERYALFGMGAVAFLGLVYYLVGPMTESASQRSSGIKS
LYVRLRNLTVILWAIYPFIWLLGPPGVALLTPTVDVALIVYLDLVTKVGFGFIA
LDAAATLRAEHGESLAGVDTDAPAVADENSHHHHHHH 
HtrII-1-134: 
MSLNVSRLLLPSRVRHSYTGKMGAVFIFVGALTVLFGAIAYGEVTAAAATGD
AAAVQEAAVSAILGLIILLGINLGLVAATLFGDTAASLSTLAAKASRMGDGDL
DVELETRREDEIGDLYAAFDEMRQSVRTSCITGDALVALPEGESVRIADIVPGA
RPNSDNAIDLKVLDRHGNPVLADRLFHSGEHPVYTVRTVEGLRVTGTANHPL
LCLVDVAGVPTLLWKLIDEIKPGDYAVIQRSAFSVDCAGFARGKPEFAPTTYT
VGVPGLVRFLEAHHRDPDAQAIADELTDGRFYYAKVASVTDAGVQPVYSLR
VDTADHAFITNGFVSHATGLTGLNSGLTTNPGVSAWQVNTAYTAGQLVTYN
GKTYKCLQPHTSLAGWEPSNVPALWQLQ 
HtrII-83-210: 
MGGDTAASLSTLAAKASRMGDGDLDVELETRREDEIGDLYAAFDEMRQSVR
TSLEDAKNAREDAEQAQKRAEEINTELQAEAERFGEVMDRCADGDFTQRLDA
ETDNEAMQSIEGSFNEMMDGIEALVGLEHHHHHH 
HtrII-83-157: 
MKIEEGKLVIGSLEGCFAKGTNVLMADGSIECIENIEVGNKVMGKDGRPREVI
KLPRGRETMYSVVQKSQHRAHKSDSSREVPELLKFTCNATHELVVRTPRSVR
RLSRTIKGVEYFEVITFEMGQKKAPDGRIVELVKEVSKSYPISEGPERANELVE
SYRKASNKAYFEWTIEARDLSLLGSHVRKATYQTYAPILYENDHFFDYMQKS
KFHLTIEGPKVLAYLLGLWIGDGLSDRATFSVDSRDTSLMERVTEYAEKLNLC
AEYKDRKEPQVAKTVNLYSKVVRGASTNPGVSAWQVNTAYTAGQLVTYNG
KTYKCLQPHTSLAGWEPSNVPALWQLQGGHGGIRNNLNTENPLWDAIVGLGF
LKDGVKNIPSFLSTDNIGTRETFLAGLIDSDGYVTDEHGIKATIKTIHTSVRDGL
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VSLARSLGLVVSVNAEPAKVDMNVTKHKISYAIYMSGGDVLLNVLSKCAGSK
KFRPAPAAAFARECRGFYFELQELKEDDYYGITLSDDSDHQFLLGSQVVVQN
GGDTAASLSTLAAKASRMGDGDLDVELETRREDEIGDLYAAFDEMRQSVRTS
LEDAKNAREDAEQAQKRAEEINT 
HtrII-83-135: 
MKIEEGKLVIGSLEGCFAKGTNVLMADGSIECIENIEVGNKVMGKDGRPREVI
KLPRGRETMYSVVQKSQHRAHKSDSSREVPELLKFTCNATHELVVRTPRSVR
RLSRTIKGVEYFEVITFEMGQKKAPDGRIVELVKEVSKSYPISEGPERANELVE
SYRKASNKAYFEWTIEARDLSLLGSHVRKATYQTYAPILYENDHFFDYMQKS
KFHLTIEGPKVLAYLLGLWIGDGLSDRATFSVDSRDTSLMERVTEYAEKLNLC
AEYKDRKEPQVAKTVNLYSKVVRGASTNPGVSAWQVNTAYTAGQLVTYNG
KTYKCLQPHTSLAGWEPSNVPALWQLQGGHGGIRNNLNTENPLWDAIVGLGF
LKDGVKNIPSFLSTDNIGTRETFLAGLIDSDGYVTDEHGIKATIKTIHTSVRDGL
VSLARSLGLVVSVNAEPAKVDMNVTKHKISYAIYMSGGDVLLNVLSKCAGSK
KFRPAPAAAFARECRGFYFELQELKEDDYYGITLSDDSDHQFLLGSQVVVQN
GGDTAASLSTLAAKASRMGDGDLDVELETRREDEIGDLYAAFDEMRQSVRTS 
HtrII-83-534: 
MGGDTAASLSTLAAKASRMGDGDLDVELETRREDEIGDLYAAFDEMRQSVR
TSLEDAKNAREDAEQAQKRAEEINTELQAEAERFGEVMDRCADGDFTQRLDA
ETDNEAMQSIEGSFNEMMDGIEALVGRIERFADAVSEDAEAVRANAESVMEA
SEDVNRAVQNISDAAGDQTETVQQIALEMDDVSATTEEVAASADDIAKTARQ
AAETGEAGRETAETAITEMNEVESRTEQAVASMEELNEDVREIGEVSEMIADI
AEQTNILALNASIEAARADGNSEGFAVVADEVKALAEETKAATEEIDDLIGTV
QDRTQTTVDDIRETSDQVSEGVETVEDTVDALERIVDSVERTNDGIQEINQSTD
AQADAAQKATTMVEDMAATSEQTASDAETAAETTETQAESVKEVFDLIDGLS
EQADTLSETLRRTDTEEASAADLDDQPTLAAGDDLEHHHHHH 
NarQ-1-231: 
MIVKRPVSASLARAFFYIVLLSILSTGIALLTLASSLRDAEAINIAGSLRMQSYR
LGYDLQSGSPQLNAHRQLFQQALHSPVLTNLNVWYVPEAVKTRYAHLNANW
LEMNNRLSKGDLPWYQANINNYVNQIDLFVLALQHYAERKMLLVVAISLAG
GIGIFTLVFFTLRRIRHQVVAPLNQLVTASQRIEHGQFDSPPLDTNLPNELGLLA
KTFNQMSSELHKLYRSLEHHHHHH 
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NarX-1-225: 
MLKRCLSPLTLVNQVALIVLLSTAIGLAGMAVSGWLVQGVQGSAHAINKAGS
LRMQSYRLLAAVPLSEKDKPLIKEMEQTAFSAELTRAAERDGQLAQLQGLQD
YWRNELIPALMRAQNRETVSADVSQFVAGLDQLVSGFDRTTEMRIETVVLVH
RVMAVFMALLLVFTIIWLRARLLQPWRQLLAMASAVSHRDFTQRANISGRNE
MAMLGTALNNMSAELAELEHHHHHH 
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Appendix III 
PDB Accession codes 
4GY6  NpSRII/HtrII-157 ground state 
4GYA  NpSRII/HtrII-135 ground state 
4GY8  NpSRII/HtrII-157 M state 
4J1D  NpSRII/HtrIIG83F-135 ground state 
4GYC  NpSRII-D75N/NpHtrII ground state 
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Abstract 
Membrane proteins are one of the main components of cell membranes and have a 
variety of functions. Studies of membrane proteins are of big importance for understanding 
the key processes that maintain a cell in a viable state. Despite the well-established 
importance and wide interest, the number of the structures of membrane proteins available at 
the moment is small. The rate of appearance of membrane protein structures is lagging 
considerably from that for water-soluble proteins. The reasons for that are difficulties that 
researchers encounter of all stages of protein preparation.  
Two-component signaling systems is an important class of proteins. In contrast to 
eukaryota, most prokaryotic signal transduction pathways use schemes of phosphate transfer 
involving two conserved components, a histidine protein kinase and a response regulator 
protein. To the moment, hundreds of such systems were found in eubacteria, archaea, and a 
few eukaryotic organisms. These systems serve as a basic stimulus-response coupling 
mechanism to allow organisms to sense and respond to changes in many different 
environmental conditions.  Though many advances in the field of signal transduction in two-
component signal transduction have been made recently, there is still a strong demand for 
robust model systems where molecular mechanism of signal transduction can be studied. The 
complex of two membrane proteins from Halobacterium N.pharaonis, Sensory Rhodopsin II 
(SRII) with its cognate Transducer (HtrII) is an example of such system. It is serving as a 
phototaxis receptor that helps halobacteria to avoid harmful UV light. Sensory rhodopsin II 
belongs to the family of archaeal retinal proteins. HtrII is highly homologous to bacterial 
chemoreceptors. It consists of transmembrane domain, linker domain, methylation region 
involved in adaptation and kinase domain.     
The X-Ray structures of SRII/HtrII give a unique insight into the complex of two 
transmembrane proteins. These structures elucidate initial steps of signal transduction in SRII 
and possible mechanism to transfer the signal to HtrII.  NMR structures of cytoplasmic 
domain of osmotic sensor EnvZ from E.coli have shown the design of kinase domain that is 
highly conserved among all histidine kinases.  Despite some structural information available 
there is still no detailed molecular mechanism of functioning of the complex from the initial 
step of retinal isomerization to phosphate group transition to the kinase CheA. This work is 
aimed to elucidate some of these steps in more detail and to show by means of X-Ray 
structural analysis the key features of protein structures that are prerequisite for efficient 
signal transduction. 
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All halobacterial retinal proteins share common features of the signal transduction 
mechanism. One of these features is a proton transfer from the Schiff base to the counterion 
after retinal isomerization. Various studies have shown that the mutation of the counterion to 
a neutral amino acid residue is critical for the function of most of them. In the case of 
SRII/HtrII complex, physiological experiments have shown that Asp75-to-Asn75 mutation 
doesn’t inhibit the signal transduction that is seen as persistent rate of cell motion reversals 
upon light illumination. This fact is important for understanding signal transduction 
mechanism in these systems. The structure described in this thesis shows the change in the 
hydrogen network of SRII-D75N/HtrII complex with respect to the wild type complex. 
Comparison with the ground and M states of the wild type has helped to elucidate how the 
signal transduction process might evolve in the D75N mutant protein. 
Intense crystallization under various conditions has resulted into another finding that 
might be very important for understanding of the mechanism of functioning. Crystals of 
different space groups were produced and the structures in these space groups were compared 
to the previously published structures in the P21212 space group. A striking difference in the 
arrangement of the SRII and HtrII proteins in the complex were observed. Whereas in the 
P21212 space group the proteins form a crevice with an opening towards cytoplasmic side 
(“V”-shape), in newly obtained structure of I212121 space group proteins are roughly parallel 
to each other (“U”-shape). This thesis contains a discussion about which of the quaternary 
structures of the complex represents the functional complex that occurs in vivo.  
Histidine kinase chemoreceptors are another representative of two-component signal 
transduction systems. NarQ and NarX belong to the family of histidine kinase receptors and 
react to nitrate or nitrite to regulate anaerobic respiration in various bacteria. This study has 
revealed some approaches that can be used in studying these very important proteins. First 
crystals were obtained. The membrane domain of the nitrate/nitrite receptor NarQ from E.coli 
was successfully expressed, purified and crystallized. At the moment these crystals require 
additional optimization. 
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Abstract 
Membranproteine sind ein Hauptbestandteil von Zellmembranen und erfüllen dort 
unterschiedliche Funktionen. Die Untersuchung von Membranproteinen ist von großer 
Bedeutung für das Verständnis der Prozesse, die eine Zelle am Leben halten. Obwohl die 
wichtige Rolle von Membranproteinen bekannt und von großem Interesse ist, ist die Struktur 
der meisten Membranproteine bisher nicht untersucht. Die Aufklärung der Struktur von 
Membranproteinen macht deutlich langsamere Fortschritte als die wasserlöslicher Proteine. 
Dies ist auf Schwierigkeiten in allen Phasen der Proteinpräparation zurückzuführen.  
Zweikomponenten-Signaltransduktionsproteine sind eine wichtige Proteinklasse. 
Anders als bei Eukaryoten kommt in den meisten Prokaryoten bei der Signaltransduktion ein 
Schema des Phosphattransfers zum Tragen, an dem zwei konservierte Proteinkomponenten 
beteiligt sind: eine Histidinkinase und ein Antwortregulator. Bis heute wurden hunderte 
solcher Systeme in Eubakterien, Archaeen, sowie in einigen eukaryotischen Organismen 
gefunden.  Diese Systeme dienen als einfacher Mechanismus der Kopplung zwischen 
Stimulus und Antwort, der es Organismen erlaubt, Veränderungen verschiedener 
Umweltbedingungen wahrzunehmen und auf sie zu reagieren.  Obwohl bei der Erforschung 
der Signaltransduktion in Zweikomponentensystemen in letzter Zeit viele Fortschritte 
gemacht wurden, besteht noch immer ein großer Bedarf an zuverlässigen Modellsystemen, 
mit denen die molekularen Mechanismen der Signaltransduktion untersucht werden können. 
Ein aus zwei Membranproteinen – dem sensorischen Rhodopsin II (SRII) und dem 
zugehörigen Transducer (HtrII) – bestehender Komplex in dem Halobakterium N. pharaonis 
ist ein Beispiel für ein solches System. Als Phototaxis-Rezeptor hilft dieser Komplex 
Halobakterien bei der Vermeidung schädlichen UV-Lichts. Das Sensor Rhodopsin II gehört 
zur Familie der archaealen Retinalproteine. HtrII weist eine starke Homologie zu bakteriellen 
Chemorezeptoren auf. Es besteht aus einer Transmembrandomäne, einem Linkerbereich, 
einer Methylierungsdomäne, die an der Adaption beteiligt ist, und einer Kinasedomäne.     
Die Röntgenstrukturen von SRII/HtrII geben einen einzigartigen Einblick in den 
Komplex aus zwei Transmembranproteinen. Diese Strukturinformationen erklären die ersten 
Schritte der Signaltransduktion in SRII und einen möglichen Mechanismus der 
Signalübermittlung an HtrII.  NMR-Strukturinformationen der zytoplasmatischen Domäne 
des osmosensorischen EnvZ aus E. coli zeigen den Aufbau der Kinasedomäne. Obwohl 
mehrere Strukturinformationen vorliegen, sind die Details der Funktionsweise des Komplexes 
auf molekularer Ebene, von der Isomerisierung des Retinals zum Übergang einer 
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Phosphatgruppe zur Kinase CheA, noch immer unbekannt. Diese Arbeit soll einen Beitrag zur 
Aufklärung einiger dieser Schritte leisten und mit Hilfe der Röntgenstrukturanalyse die 
wichtigsten Eigenschaften von Proteinstrukturen zeigen, die eine effiziente Signaltransduktion 
möglich machen. 
Der Mechanismus der Signaltransduktion weist bei allen halobakteriellen 
Retinalproteinen einige Gemeinsamkeiten auf. Eine dieser Gemeinsamkeiten ist ein 
Protonentransfer von der Schiff Base zum Gegenion, der nach der  Isomerisierung des 
Retinals stattfindet. Verschiedene Studien haben gezeigt, dass die Mutation des Gegenions zu 
einem neutralen Aminosäurerest in vielen Fällen kritisch für die Funktion ist. Im Fall des 
SRII/HtrII-Komplexes haben physiologische Versuche gezeigt, dass die Mutation von Asp75 
zu Asn75 die Signaltransduktion, die als persistente Rate der Umkehrung von 
Zellbewegungen bei Lichteinfall gilt, nicht hemmt. Diese Tatsache ist wichtig, um den 
Mechanismus der Signaltransduktion in diesen Systemen zu verstehen. Die in dieser Arbeit 
beschriebene Struktur zeigt die Veränderung im Wasserstoffnetzwerk vom SRII-D75N/HtrII-
Komplex im Vergleich zum Wildtyp-Komplex. Ein Vergleich mit dem Grundzustand und 
dem M-Zustand des Wildtyps konnte Hinweise darauf geben, wie die Signaltransduktion in 
der D75N-Proteinvariante möglicherweise abläuft. 
Die intensive Kristallisierung unter verschiedenen Bedingungen hat zu einem weiteren 
Ergebnis geführt, das für das Verständnis des Funktionsmechanismus ebenfalls von großer 
Bedeutung sein könnte. Es wurden Kristalle hergestellt, die unterschiedliche Raumgruppen 
aufwiesen, und die Strukturinformationen für diese Raumgruppen wurden mit den vorher 
veröffentlichen Daten zur Raumgruppe P21212 verglichen. Dabei wurde ein auffallender 
Unterschied in der Anordnung der SRII- und HtrII-Proteine innerhalb des Komplexes 
festgestellt. Während die Proteine in der Raumgruppe P21212 einen "Spalt" bilden, der zur 
zytoplasmatischen Seite hin offen ist ("V-Form"), sind sie in der neuen Struktur der 
Raumgruppe I212121 etwa parallel angeordnet ("U-Form"). In dieser Arbeit wird diskutiert, 
welche der Quartärstrukturen des Komplexes den in vivo vorkommenden funktionalen 
Komplex darstellt.  
Histidinkinasen sind ein weiteres Beispiel für Zweikomponentensysteme zur 
Signaltransduktion. NarQ und NarX sind solche Histidinkinasen, die als Rezeptor für Nitrat 
und Nitrit dienen, d. h. auf diese Substanzen reagieren, um die anaerobe Atmung in 
verschiedenen Bakterien zu regulieren. Diese Arbeit zeigt einige Ansätze, die bei der 
Untersuchung dieser sehr wichtigen Proteine zur Anwendung kommen können. Dazu wurden 
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zunächst Kristalle gewonnen. Die Membrandomäne des Nitrat/Nitrit-Rezeptors NarQ aus E. 
coli wurde erfolgreich exprimiert, gereinigt und kristallisiert. Derzeit erfordern diese Kristalle 
jedoch noch weitere Optimierung. 
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